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Chapter 1 
General introduction 

1. General introduction 
Genetic diseases can be classified into three main categories. Chromosomal 
disorders are characterized by the lack, excess, or abnormal arrangement of 
one or more chromosomes, resulting in a deficient or aberrant expression 
pattern of the respective genes. Mendelian or monogenic disorders are 
determined by a single mutant gene. Based on the origin of the mutation and 
its mode of action, this group can be subdivided into autosomal recessive, 
autosomal dominant and X-linked phenotypes. Multifactorial disorders are 
caused by the interaction of multiple genetic and exogenous factors and 
therefore, exhibit a complex pattern of inheritance. Together, genetic 
conditions account for a significant percentage of illness. About 5 percent of 
live-born individuals below age 25 have a disease with an important genetic 
component. Including late-onset multifactorial disorders, the life-time risk to 
develop a genetic disease is about 60% [Beaudet et al, 1989]. 
These figures, however, do not reflect the true dimensions of genetic risk. 
Approximately 15% of all pregnancies are terminated early and it has been 
estimated that this proportion might even reach 50% when all conceptions 
are considered. Taking into account that chromosomal defects are found in 
50% of first-trimester spontaneous abortions, serious chromosome anomalies 
may be present in about a quarter of all conceptions [Gelehrter & Collins, 
1990]. 
The role of the 'genetic background' in infectious diseases and in behavioral 
problems such as drug abuse or learning disabilities, once thought to 
represent clear examples of non-genetic conditions, has recently become 
apparent [for recent reviews, see Bouchard, 1994; Cardon et al, 1994; Mann, 
1994; Plomin et al, 1994]. The study of the causative genes and their relation 
to environmental factors will broaden our understanding of the nature and 
extent of the genetic contribution to human variation and disease. Thus, 
research in the field of human and medical genetics will not only be crucial for 
the ultimate treatment and/or prevention of clinical conditions but will also 
provide insights into basic biological principles. 
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1 . 1 . Localization and isolation of disease genes 
During the last decade, the application of molecular-biological techniques and 
in particular, recombinant DNA technology has provided a wealth of 
information and remarkable insights into the molecular basis of genetic 
disease. Numerous strategies for the identification and localization of disease 
genes have been developed. In principle, two major approaches can be 
distinguished, the choice of which is usually dictated by the available 
knowledge of the disease. 
Functional cloning of genes requires information on the respective protein, and 
its amino acid (aa) sequence. Based on this sequence, sets of corresponding 
(degenerated) oligonucleotides can be designed which are suitable as probes 
for direct hybridization or for a polymerase chain reaction (PCR)-based 
screening of cDNA libraries. An alternative strategy involves the use of 
specific antibodies against the protein in question to identify corresponding 
cDNA clones in cDNA-expression libraries. Generally, additional investigations 
are necessary to confirm the identity of the positive clones and to rule out the 
possibility of cross-reactivity to polypeptides with related or shared epitopes. 
The functional cloning strategy has been successfully employed for the 
elucidation of hereditary metabolic disorders, such as phenylketonuria [Kwok 
et al, 1985], steroid sulfatase (STS) deficiency [Yen et al, 1987], and 
glucose-6-phosphate dehydrogenase (G6PD)- deficiency [Persico et al, 1986]. 
When neither structural data nor antibodies are available, the function of a 
protein or its interaction with other proteins may be used to identify the 
corresponding gene. To isolate a gene by complementation, a cDNA-
expression library can be transfected into a mutant cell line that is deficient in 
a certain function. Transfection of the corresponding wild type cDNA will 
cause reversion of the mutant phenotype thereby restoring the normal 
function. The FAH gene which is altered in patients with Fanconi anemia type 
I, a defect of the DNA repair machinery, is one of the genes that have been 
cloned by this method [Strathdee et al, 1992]. 
In contrast, positional cloning of genes relies on the knowledge about their 
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genetic and/or physical location in the genome. This strategy is particularly 
valuable if the biochemical defect underlying a genetic disorder is not known. 
This is true for most of the Mendelian disorders known to date. 
Because of their dual character as genetic and physical markers, DNA 
polymorphisms are ideal tools for the chromosomal mapping of inherited 
traits. The genetic map of man comprises more than 2000 polymorphic DNA 
markers with known map positions in the human genome [for a recent update, 
see Gyapay et al, 1994]. The first genetic maps were based on linkage 
studies with restriction fragment length polymorphisms (RFLPs), which require 
Southern blotting experiments for their detection. In view of their low 
information content [Botstein et al, 1980], which is due to the fact that most 
RFLPs are bi-allelic, and because their analysis is laborious and time-
consuming, RFLP studies have been widely replaced by PCR-based methods 
to detect highly polymorphic tandem repeat markers such as the so-called mini-
or microsatellites [e.g., see Jeffreys et al, 1985; Nakamura et al, 1987; 
Weber & May, 1989]. Linkage between these markers and inherited gene 
defects can be established when a certain allele of the polymorphic marker co-
segregates with the disease phenotype in an affected family, i.e. when both 
are transmitted jointly to the offspring and are not distributed independently 
as one would expect from the laws of Mendel [Mendel, 1865]. Through 
linkage analysis and sufficient numbers of (doubly) informative individuals 
within a single pedigree, the position of the relevant gene can be narrowed 
down to a few centiMorgan (cM). In man, a genetic distance of 1 cM 
corresponds, on average, to a physical distance of 1 million basepairs (bp). 
Until a few years ago, no molecular techniques were available to bridge 
megabase-range physical distances. Therefore, the so-called 'Southern gap' 
between the resolution of genetic analysis (down to 5 χ 10e bp) and the range 
of molecular analysis (up to 5 χ 10 s bp) made it difficult to proceed from a 
genetically defined map position to the molecular cloning of the gene. Only 
recently, have long-range restriction mapping techniques and appropriate 
cloning vectors become available which have significantly extended the range 
of molecular analysis and cloning and have allowed the bridging of this gap. 
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Using infrequently-cutting restriction enzymes, large DNA fragments in the 
megabase (Mb)- range can be generated, separated by pulsed field gradient 
gel electrophoresis (PFGE) [Schwartz and Cantor, 1984] or field inversion gel 
electrophoresis (FIGE) [Carle et al, 1986] and analyzed with suitable DNA 
probes. While DNA probes were initially isolated by random selection and 
mapping of clones from genomic libraries, region-specific libraries can 
nowadays be constructed by means of microdissection [Lüdecke et al, 1989; 
MacKinnon et al, 1990], preparative PFGE or FIGE [Michiels et al, 1987; 
Anand et al, 1988; van de Poi et al, 1990], or the subcloning of radiation 
reduced hybrids [Cox et al, 1990]. Further progress has been made with the 
development of "chromosomal jumping" techniques. Large DNA fragments, 
generated either by random fragmentation and subsequent size selection or 
complete digestion with an infrequently-cutting restriction enzyme ('rare-
cutter'), are linked to a selectable marker and circularized. Subsequently, the 
large circular molecule is digested with another restriction enzyme and the 
junction fragment carrying both ends of the genomic DNA fragment and the 
selective marker is isolated. Such 'jumping clones' therefore juxtapose new 
DNA sequences within a defined range of distance and in a specified direction 
from a given DNA probe [Collins et al, 1984; 1987]. In a complementary 
approach, clones containing recognition sites of 'rare-cutters' are selected, 
which yield so-called 'linking clones' that join the ends of adjacent restriction 
fragments [Smith et al, 1986; Arenstorf et al, 1991]. In conjunction, 
'jumping' and 'linking' libraries can be used to saturate large chromosomal 
regions with DNA markers. 
In order to clone the region between two markers, vectors such as the P1 
bacteriophage system [Sternberg, 1990; 1994], modified F+- episomes (also 
designated as Bacterial Artificial Chromosomes or BACs) [O'Connor et al, 
1989; Hosoda et al, 1990], and the Yeast Artificial Chromosome (YAC) 
system [Burke et al, 1987] have been designed. Because of their considerable 
advantages (insert size up to 2 Mb, stability, easy manipulation, possible 
introduction and expression in mammalian cells) YACs have become the 
preferred system to analyze large chromosomal regions. Recently, Sun and 
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coworkers [1994] reported on the development of a new cloning system. 
Human Artificial Episomal Chromosomes (HAEC), which should not only 
become a valuable tool for functional studies but also opens up exciting 
prospects for gene therapy. 
Once a region of interest is covered by a set of overlapping YAC clones, these 
YACs can be subcloned into cosmids or phages or used directly [Elvin et al, 
1990] to search for evolutionary conserved and/or expressed sequences. 
Subtractive cDNA selection [Lovett et al, 1991], exon trapping [Buckler et al, 
1991], and screening of cDNA libraries, 'Zoo'- blots [Monaco et al, 1986] 
and/or Northern blots with non-repetitive (i.e. single copy) DNA sequences are 
routinely employed for this purpose. 
With the introduction of automated sequencing more direct approaches have 
been used for the identification of genes. Large stretches of genomic DNA can 
be sequenced and searched for potential open reading frames (ORFs) by 
computer analysis, a strategy that has been employed for the cloning of the 
Kallmann syndrome gene [Legouis et al. 1991]. Predicting coding regions from 
genomic sequences, however, is not entirely accurate, a limitation that can be 
overcome by analysing cDNA clones in addition to genomic sequences. A few 
years ago, the first reports appeared describing an approach for the large-
scale, partial sequencing of random cDNAs [Adams et al, 1991; Wilcox et al, 
1991]. By single pass sequencing into the 5' and/or 3' end of cDNA clones 
so-called expressed sequence tags (ESTs) can be generated. While sequences 
from the 5' end will be enriched for ORFs (and therefore are suitable for the 
identification of sequence similarities to proteins of known function), 
sequences from the 3' end may provide highly specific PCR primer pairs that 
will facilitate the physical localization of the corresponding gene. Thus, ESTs 
can serve as valuable reference points in the genome, e.g. for the assembly of 
an integrated genome map, and for the identification of candidate genes for 
disorders already mapped to a defined region. 
This method is now being applied to a variety of tissues and developmental 
stages in order to obtain characteristic profiles of the genes expressed in the 
respective tissues and their relative abundances (e.g., see Sikela & Auffray, 
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1993]. So far, more than 50,000 ESTs have been recorded in the public 
database of partial cDNA sequences (dbEST, GENBANK) [Boguski et al, 
1994], more than 32,000 of which belong to human genes [Cohen & 
Emanuel, 1994]. Within the next 18 months the number of known ESTs will 
probably increase more than tenfold: 400,000 ESTs specifying both ends of 
200,000 human cDNA clones will be generated in a large-scale effort that is 
supported by industry [Williamson & Elliston, 1994; Cohen & Emanuel, 1994]. 
With the increasing power of database facilities so-called 'positional candidate 
gene approaches' will become an increasingly common means of disease gene 
identification, as has been demonstrated for the L1CAM gene involved in X-
linked hydrocephalus [Rosenthal et al, 1992], X-linked liver Phosphorylase 
kinase deficiency [van den Berg et al, 1995] or the human glycerol kinase 
(GK) gene. The latter gene was identified when a randomly isolated expressed 
sequence tag (EST), homologous to the glycerol kinase gene of E.coli, was 
mapped to the human Xp21 region [Sargent et al, 1993] which was known to 
carry the human GK gene [Guo et al, 1993]. 
After the isolation of a candidate gene, its identity with the respective disease 
gene has to be verified. Detailed analyses of the gene (structure, regulatory 
motifs) and its transcript/protein (spatiotemporal expression) as well as 
database searches may provide clues to the function of the encoded protein. 
Finally, the demonstration of subtle mutations in affected individuals will 
establish the link between this gene and the disease. 
Despite the growing number of genes isolated by positional cloning there are 
still significant constraints of this approach. Most of the applied methods are 
laborious and time-consuming. Another disadvantage is that only a certain 
subset of disease genes is likely to be identified by this approach, i.e. genes 
responsible for disorders with a relatively high prevalence (implying sufficient 
family material for linkage analysis) and genes that are involved in 
chromosomal rearrangements (illustrated for X-chromosomal genes that have 
been isolated by positional cloning techniques; Table 1). 
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Table 1 : X-chromosomal genes isolated by means of positional cloning 
disease 
Kallmann syndrome 
X-hnked chondrodysplasia 
punctata 
Ocular albinism 
Duchenne muscular 
dystrophy 
Chromo granulomatous 
disease 
McLeod syndrome 
Glycerol kinase 
deficiency 
X-linked adrenal 
hypoplasia congenita 
Aarakog-Scott syndrome 
Wiskott-Aldrich 
syndrome, X-linked 
thrombocytopenia 
Synovial sarcoma 
Nome disease 
Severe combined 
immunodeficiency 
Menkes syndrome 
Deafness 3 
Choroidererrua 
localization 
X p 2 2 . 3 
Xp22.3 
X p 2 2 . 3 
Xp21 
Xp21 
Xp21 
Xp21 
Xp21 
X p 1 1 . 2 
X p 1 l . 2 
Χ ρ Π . 2 
X p l l . 2 
Xq13.1 
X q l 3 3 
Xq21.1 
Xq21 2 
cloning aided by 
contigous gene deletions, 
translocations 
linkage, 
contigous gene deletions 
linkage, 
contigous gene deletions 
linkage, contigous gens 
delations, translocations 
linkage, contigous gene 
deletions, 
expression studies 
contigous gene deletions 
contigous gene deletions 
contigous gene deletions 
linkage, translocations 
linkage, 
expression studies 
translocations 
linkage, 
deletions, translocations 
linkage, 
candidate gene approach 
linkage, translocations 
linkage, 
contigous gene deletions 
linkage, translocations 
contigous gene deletions 
reference 
Franco et al, 1 9 9 1 
Legouis et al, 1 9 9 1 
Franco et al, 1 9 9 5 
Bassi et al, 1 9 9 5 
Monaco et al, 1 9 8 6 
Royer-Pokora et al, 1 9 8 6 
Ho et al, 1 9 9 4 
Walker et al, 1 9 9 3 
Zanana et al, 1 9 9 4 
Pastens et al, 1 9 9 4 
Derry et al, 1 9 9 4 
Villa et al, 1 9 9 5 
Clark et al, 1 9 9 4 
Berger et al, 1 9 9 2 
Chen et al, 1 9 9 2 
Noguchi et al, 1 9 9 3 
Puck et al, 1 9 9 3 
Chelly s t a i , 1 9 9 3 
Mercer et al, 1 9 9 3 
Vulpe et al, 1 9 9 3 
this thesis 
Cremers et al, 1 9 9 0 
Merry et al, 1 9 9 2 
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Table 1: continued 
disease 
X-linked (Bruton's) 
agammaglobulinemia 
Lowe oculocerebrorenal 
syndrome 
Adrenoleukodystrophy 
Fragile X syndrome 
Fra(X)E mental retardation 
I Emery-Dreifuss muscular 
dystrophy 
localization 
Xq22.1 
Xq25 
Xq27 
Xq27.3 
Xq28 
Xq28 
cloning aided by 
linkage 
linkage, translocation 
deletions 
cytogenetics, linkage, 
translocations 
cytogenetics 
linkage 
reference 
Vetrie et al, 1993 | 
Attree et al, 1992 
Mosser et al, 1993 
Verkerketal, 1991 
Knight étal, 1993 
Bione et al, 1994 
Unfortunately, cloning and structural characterization of disease genes do not 
necessarily provide insight into the biological function of the encoded protein, 
nor into the pathogenesis of the relevant disease. In this context, the 
sequence of events which led to the molecular elucidation of the X-linked eye 
disease choroideremia (CHM) is particularly illustrative. The CHM gene, which 
is involved in progressive retina degeneration, was one of the first genes to be 
isolated by positional cloning techniques [Cremers et al, 1990; Merry et al, 
1992; van Bokhoven et al, 1994a]. The identity of the gene was confirmed 
by the demonstration of various intragenic mutations in choroideremia 
patients [van den Hurk et al, 1992; Sankila et al, 1992; Schwartz et al, 1993; 
van Bokhoven et al, 1994b; Donnelly et al, 1994]. However, the function of 
the gene and its role in the aetiology of CHM remained unresolved until 
biochemical research into a certain class of post-translational modification 
enzymes revealed significant homology between the amino acid sequence of 
the 95 kiloDalton stimulator of rat Rab geranylgeranyl transferase and the 
murine and human CHM proteins [Seabra et al, 1992]. Subsequent functional 
studies on EBV-immortalized peripheral blood cells of CHM patients further 
strengthened the hypothesis that the primary defect of choroideremia is due 
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to a failure in post-translational prenylation of Rab molecules in the retina 
[Seabra et al, 1993]. 
Apart from underlining the value of DNA and aa sequence comparisons, this 
example demonstrates the importance of biochemical and cell biological 
investigations for the subsequent characterization of disease genes. Especially 
the analysis of mutations and their consequences for the pathogenesis of a 
disease will require the combination of biochemical and molecular genetic 
techniques. 
A promising, though time-consuming approach to elucidate the pathogenetic 
role of genes and their defects is the use of transgenic animals [e.g., see 
Jaenisch, 1989; Gatherer, 1993]. The ability to introduce and to express in 
wf/O-manipulated genes in the germ line of model organisms like mice [for 
technical details, see Joyner, 1993] has overcome the limitations of cell 
culture studies, which do not allow the study of mutations involving 
developmental processes. Since, in principle, any type of mutation (e.g. null 
['knock out'] mutations, point mutations, deletions or exchange of functional 
domains) can be introduced in this way, it has become possible to generate 
animal models for a great variety of human hereditary diseases. These models 
are invaluable for studying mutational effects as well as normal gene function. 
Insertional mutagenesis in model organisms represents another strategy to 
identify and characterize disease genes. By random insertion of foreign DNA 
sequences into the genome of an animal host, disruption of endogenous 
genes can be achieved which sometimes leads to a phenotype resembling a 
human disorder. This approach has proven to be useful for establishing mouse 
models for various disorders, e.g. autosomal recessive polycystic kidney 
disease [Moyer et al, 1994]. 
The above-mentioned strategies have proven extremely useful for the 
elucidation of simple Mendelian traits but their application to the identification 
of genetic factors underlying complex traits like hypertension, neural tube 
defects, cancer, diabetes, or heart diseases has been far less fruitful. 
Although a few genes involved in multifactorial diseases have been discovered 
by association studies and conventional linkage analysis (e.g. susceptibility 
loci for insulin dependent diabetes mellitus [IDDM1-5, reviewed in Thomson, 
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1994]), most of the genes with weaker influences on the disease phenotype 
are much more difficult to map. This can partly be attributed to incomplete 
penetrance, genetic heterogeneity and/or the high frequency of a disease-
causing allele [Lander & Schork, 1994]. New techniques such as genomic 
mismatch scanning (GMS) and the representational difference analysis (RDA) 
are likely to circumvent some of the problems mentioned above and should be 
very useful for dissecting complex traits [Aldhouse et al, 1994]. 
Genetic research seems to be entering a qualitatively new stage. The 
construction of a high-resolution integrated map for the human genome 
(combining the genetic map and its physical counterpart) will permit the rapid 
localization of newly identified genes. With the facilities already available and 
the advances that will be made in the future. Human Genetics will change 
from a descriptive discipline to an explanatory one that integrates its 
principles and knowledge into medicine and other natural sciences. 
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1.2. The human X-chromosome 
The human X-chromosome has been studied in more detail than other 
chromosomes which has resulted in a very well-defined map of the X-
chromosome. At present, the genetic linkage map contains 80 markers 
spanning the whole chromosome with an average distance of 2 cM (except 
for a single large gap of 18 cM) [Gyapay et al, 1994]. More than 120 Mb of 
the X-chromosome (80%) is physically represented in YAC contigs and more 
than 130 X-linked genes have been cloned and regionally mapped [Willard et 
al, 1994]. The characteristic inheritance pattern of X-linked diseases as well 
as the wide availability of patients with X-chromosomal rearrangements such 
as deletions, duplications and translocations (93 breakpoints involving the X-
chromosome have been reported at the Fourth International Workshop on 
Human X Chromosome Mapping, St. Louis, USA) have favoured the mapping 
and cloning of X-chromosomal disease genes and their normal counterparts 
[Schlessinger et al, 1993]. 
Most of the male-viable deletions have been recognized in the dark-staining 
Giemsa bands Xp21 and Xq21 [e.g. Francke et al, 1985; Cremers et al, 1988] 
and in Xp22.3 [Ballabio, 1991]. It has been proposed that dark-staining 
chromosomal bands are relatively poor in functional genes [Kurnit & Hoehn, 
1979; Ropers et al, 1987] which is in keeping with the concept that these 
late-replicating regions are more condensed than light-staining Giemsa bands 
[for review, see Bickmore et al, 1989]. Selective pressure against structural 
aberrations might be considerably reduced in such 'empty' chromosomal areas 
allowing for unbalanced chromosomal rearrangements that are compatible 
with life in the affected males. Clinically, such deletions are sometimes 
accompanied not only by a single condition but exhibit a rather complex 
phenotype in the affected males. Often this is due to a contiguous gene 
syndrome (CGS) resulting from a "deletion of a continuous stretch of DNA 
that includes multiple genes on a chromosome, each contributing to the 
phenotype in an independent manner" [Ballabio, 1991]. Definitive proof that 
one is indeed dealing with a CGS rather than pleiotropic effects of one single 
gene, can be achieved when more than one of the disease genes thought to 
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be involved in the CGS can be independently assigned to the chromosomal 
region containing the deletion event. In males, most X-chromosomal deletions 
can be readily detected because they will result in nullisomy of several X-
linked genes. Against this background, it is not surprising that since the first 
report of an X-chromosomal CGS [Francke et al, 1985] a considerable number 
of cases have been described [e.g. Wieringa et al, 1985; Francke, 1987; 
Cremers et al, 1989; Ledbetter et al, 1989; Ballabio, 1991; this thesis]. By 
molecular characterization of the underlying deletions it has proved possible to 
isolate several of the relevant disease genes (Table 1). 
Although Giemsa light-staining, the Xp22.3 band seems to be another 'hot 
spot' for unbalanced X-chromosomal rearrangements. The apparent clustering 
of structural aberrations in this region can be explained in part by illegitimate 
crossing over between low-copy repeat elements that give rise to interstitial 
deletions [Ballabio et al, 1990; Yen et al, 1990] and by abnormal pairing and 
unequal crossing over between homologous regions on Xp22.3 and Yp11.32 
resulting in terminal deletions and translocations [Ballabio et al, 1989]. It is 
not surprising that X/autosome translocations are found in Giemsa light-
staining bands, i.e. in gene-rich chromosomal segments. In general, 
translocations will only be recognized if they are associated with an abnormal 
phenotype (ascertainment bias) that is caused by the loss or disruption of 
genes or regulatory sequences during the breakage and reunion of 
chromosomal segments. 
In females with X/autosome translocations modification of the clinical 
phenotype may result from X-chromosome inactivation (XCI) [e.g., see Boyd 
et al, 1986a,b; Cremers et al, 1990; Vulpe et al, 1993]. XCI, a process found 
exclusively in mammalian somatic tissues, is necessary to compensate for the 
gene dosage inequality between sexes [Lyon, 1961]. As a result, all X-
chromosomes in excess of one become inactivated and can be recognized as 
heterochromatic, condensed Barr bodies in the nucleus. Normally, this 
inactivation is a random process, affecting either the paternal or the maternal 
X-chromosome (see below). In carriers of balanced reciprocal X/autosome 
translocations, however, transcription of genes on the normal X is usually 
silenced. This is presumably because inactivation of only one X/autosome 
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derivative, i.e. the one that carries the X-inactivation centre (XIC), would 
prevent inactivation of the normal X-chromosome as well as the other 
derivative leading to a functional disomy for all X-chromosomal genes residing 
on the non-inactivated derivative. Moreover, XCI has a tendency to spread 
from the X-chromosome to the attached autosomal segment which would 
result in a functional monosomy for this part. Thus, females heterozygous for 
such a translocation may express X-linked recessive disorders otherwise 
observed only in hemizygous males. On the other hand, in women that carry 
an unbalanced X/autosome translocation, the rearranged X-chromosome is 
usually inactivated, although the inactivation pattern varies between 
individuals and between tissues [Therman et al, 1980; Disteche et al, 1984]. 
Despite extensive investigations the mechanism of the inactivation process 
has not yet been elucidated. The recently cloned XIST gene [Brown et al, 
1991a; 1992] which is exclusively transcribed from the inactive X-
chromosome, may be directly involved in the inactivation process. Since the 
17 kb transcript of X/S7"has no significant open reading frames (ORFs) and is 
only found in the nucleus, it is likely that the functional product of this gene is 
not a protein but an RNA which may interact with proteins and/or nucleic 
acids [Hendrich et al, 1993]. XIST might exert its function by changing the 
chromatin conformation upon transcription through the locus. Such 
conformational changes may allow the binding of other factors promoting the 
inactivation process [Norris et al, 1994]. It has been postulated that early in 
embryogenesis a limiting autosomal factor is bound to the XIC of one of the 
X-chromosomes in a cell [Riggs & Pfeifer, 1992]. Since XIST and XIC map to 
the same region [Brown et al, 1991b], it is possible that this autosomal factor 
sterically blocks XIST expression on this chromosome and thereby marks it to 
remain active [Kay et al, 1993]. In contrast, the XIST gene of the sister X-
chromosome remains transcriptionally active and may initiate the inactivation 
process [Kay et al, 1993]. A more specific model is based on the differential 
methylation and expression status of maternal and paternal XIST alleles during 
early embryonic development [Kay et al, 1994; Norris et al, 1994]. A 
maternally imprinted, autosomal trans-activating factor that persists in the 
oocyte cytoplasm is proposed to bind to the hypomethylated promoter of the 
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paternal XIST allele thereby rendering it transcriptionally competent already in 
the 4-cell stage. XIST expression then leads to inactivation of the paternal X-
chromosome. In contrast, the maternal XIST allele is fully methylated in the 
totipotent cell lineage which prevents binding of the autosomal transactivator 
and XIST expression. Thus, the initial, non-random inactivation of the paternal 
X-chromosome that occurs prior to random X-inactivation in the 
extraembryonic trophectoderm and primitive endoderm lineages [Takagi &. 
Sasaki, 1975], is mediated by a parental imprint of the XIST gene. It is of 
note that all paternally derived XIST alleles are programmed to be expressed 
in normal fertilized embryos irrespective of the number of X-chromosomes 
[Kay et al, 1994]. However, this imprint is lost when a global demethylation 
occurs prior to cell differentiation [Monk et al, 1987, 1991; Monk 1990]. 
Thereafter, methylation of either XIST allele can be reset at random in the 
embryo, resulting in the expression of one of the parental XIST genes per cell 
and random X-chromosome inactivation. Several studies suggest that this 
random inactivation process occurs at different times for different tissues 
during the early phases of post-implantation development [e.g. Tan et al, 
1993 and references therein]. It is assumed that re-methylation is directed by 
a second regulatory mechanism, that comes into play at the compacting 
morula stage in order to ensure dosage equality by inactivating all 
supernumerous X-chromosomes [Kay et al, 1994]. A similar mechanism that 
assesses the ratio between the number of X-chromosomes and the sets of 
autosomes (X:A ratio) is crucial for the sex determination and dosage 
compensation in Drosophila melanogaster. Although some of the factors that 
participate in this process have been identified in fly [for review see Parkhurst 
& Meneely, 1994], the molecular basis of X-chromosome inactivation in 
mammals has yet to be elucidated. It is generally accepted that once initiated, 
the inactivation process spreads in a cis-limited manner thereby inactivating 
almost all genes along the X-chromosome. XIC (including the XIST gene) may 
have a role in this process, but it is not required for maintenance of the 
inactivated state [Brown & Willard, 1994]. 
Several genes have been reported to escape from X-inactivation (Table 2). 
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Table 2: Genes that escape X-chromosome ¡nactivation 
gene 
ANT3 
XE7 
МІС2Я 
MIC2 
XG 
IPDBX) 
GSÎX 
STS 
KALI 
ZFX 
UBE1 
ssx 
SMCX 
IXE169) 
DXS423E 
ISB1 8) 
RPS4X 
physical 
location 
Xp22.3 
Xp22.3 
Xp22.3 
Xp22.3 
Xp22.3 
Xp22 3 
Xp22 3 
Xp22.3 
Xp22.1 
Xp11.23 
Xp11.21-
p11.22 
Xp11.21-
p11.22 
Xp11.21 
Xq13.3 
function 
adenine nucleotide translocase, 
facilitates the ADP/ATP exchange 
across the mrtochondnal membrane 
unknown 
unknown 
cell surface antigen CD99 
involved in cell adhesion 
XG blood group gene 
unknown 
steroid sulphatase 
neural cell adhesion protein 
involved in axonal path finding 
zinc finger protein 
ubiquran-activating enzyme E1 
unknown 
unknown 
putative chromosome segregation 
protein 
encodes one isoform of the rlbosomal 
protein S4 that is a component of 
the 40S subunit 
expression 
ubiquitous 
ubiquitous 
ubiquitous 
ubiquitous 
adult, skin fibroblasts, 
haematopoietic tissues; 
fetal: spleen, thymus, 
adrenal, liver 
fibroblasts, placenta, kidney 
ubiquitous 
ubiquitous 
widely transcribed 
ubiquitous 
synovial sarcoma, fibrosarcoma 
ubiquitous 
venous tumour cell lines, 
fibroblasts 
ubiquitous 
references 1 
Cozens et al, 1989 В 
Schiebeletal, 1993 E 
Ellison et el, 1993 
Smith & Goodfellow, 
1994 
Goodfellow et al, 19Θ3 
Goodfellow et al, 1984 
Smith et al, 1993 
Ellis et al, 1994a,b 
Venetal, 1992 
Yenetal, 1987 
Franco et al, 1991 
Schnelder-Gadicke et al, 
1989 
Brown et al, 1989; 1990 
Clark et al, 1994, 
Miller et al, 1995 
Agulnik et al, 1994 
Brown et al, 1995 
Rocques et al, 1995 
Fisher et al, 1990 
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Most of them are located in or adjacent to the pseudoautosomal region (PAR) 
at the tip of band Xp22.3, a 2.6 Mb segment known to contain sequences 
homologous to sequences on the short arm of the Y-chromosome, i.e. in band 
Yp11.32. In contrast, the genes for the ribosomal protein S4 (RPS4X), UBE1, 
SSX, SB 1.8, and SMCX have been localized considerably apart from the PAR 
[Fisher et al, 1990; Brown & Willard, 1989; Miller et al, 1995; Ballabio & 
Willard, 1992; Agulnik et al, 1994]. X/Y-homologies are probably a relic of 
evolution. It is believed that the heteromorphic sex chromosomes in mammals 
have evolved from a homomorphic sex chromosome pair by gradual reduction 
of the Y chromosome and a series of rearrangements [Ohno et al, 1967]. The 
fact that all genes from the region of X/Y-homology (except for RPS4X) that 
escape X-chromosome inactivation in man map to Xp [Disteche, 1995], is 
indicative of an autosomal origin. It has been hypothesized that these genes 
have been acquired as later additions to the sex chromosomes, which is 
supported by the observation that genes on Xp are clustered on two different 
autosomes in monotremes and marsupials [Spencer et al, 1991]. 
Interestingly, almost all genes (except for STS, SMCX and XIST) known to 
escape X-chromosome inactivation in man are subject to inactivation in the 
mouse [Adler et al, 1991; Ashworth et al, 1991; Kay et al, 1991; Zinn et al, 
1991; Sultana et al, 1995]. It has been hypothesized that functional 
differences in the Y-linked homologues of these genes in both species, with 
the exception of XIST, are the cause of this phenomenon [Disteche, 1995]. 
While SMCX (which escapes X- inactivation in man and mouse) has a widely 
expressed Y-homologue in both species, the Y-homologues of the ubiquitously 
expressed Zfx and Ube 1x are expressed only in testis in the mouse [Disteche, 
1995 and references therein]. For these genes and others that lack a 
functional Y-homologue [e.g. Rps4x and Sbî.8, Zinn et al, 1994; Sultana et 
al, 1995] it seems therefore advantageous to ensure an equal dosage 
between male and female mice by X-inactivation. 
The differences in the X-inactivation status of human and mouse genes may 
account for the different phenotypes observed in 45,X humans and XO mice 
[Ashworth et al, 1991]. While human females that lack one X-chromosome 
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show the severe phenotype of Turner syndrome (short stature, lymphoedema, 
gonadal dysgenesis and severe fetal loss), XO mice appear almost normal 
except for a slight growth retardation, a reduced reproductive life-span and a 
moderately increased rate of fetal loss. Thus, genes that have no Y-
homologue and which escape X-inactivation in man but not in mouse are 
promising candidates for the Turner phenotype [Disteche, 1995]. 
Little is known about the inactivation mechanism itself and how its selectivity 
is maintained. In general, X-inactivation is clonally stable. Inactive 
chromosomes replicate late during the cell cycle, have a compact chromatin 
structure and can be distinguished from the active X by the presence of 
acetylated histone 4 [e.g. Gartler & Riggs, 1983; Jeppesen & Turner, 1993]. 
Moreover, most genes on the inactive X-chromosome have hypermethylated 
CpG islands [e.g. Cattanach, 1975; Riggs & Pfeifer, 1992]. In contrast, genes 
on the active X-chromosome as well as genes that escape inactivation usually 
show hypomethylation of their 5'- CpG islands which suggests that 
methylation is involved in the maintenance of the inactivation state. In 
contrast, differential methylation has neither been found in marsupials nor on 
the inactive paternal X-chromosome in the extraembryonic tissue of 
eutherians [Kafri et al, 1992; Grant et al, 1992]. Likewise, the X-
chromosomes in mouse primordial germ cells are unmethylated suggesting 
that the inactivation state is not necessarily accompanied by methylation 
[Grant et al, 1992]. Thus, methylation does not seem to be a primary factor in 
spreading and maintenance of the inactivation state, but rather a stabilizing 
modification [Lyon, 1993]. However, further studies are necessary in order to 
unravel the role and relationship of X/S7"-expression, methylation, chromatin 
structure and other, yet unknown factors involved in the X-inactivation 
process. 
19 
1.3. Genes and inner ear development 
Mammalian ear development is characterized by a series of tissue movements 
and inductive interactions that promote the differentiation of inner, middle and 
outer ear structures. It is beyond the scope of this chapter to describe the 
complete embryology of the ear. Instead, a brief overview will be given of the 
basic sequence of events in inner ear development {Fig. 1) and the role of 
genes known to be involved in this process [for a detailed anatomical 
description see Schuknecht & Gulya, 1986]. 
Figure 1 : Developmental stages of inner ear formation. 
Α-C: otic vesicle formation in post-implantation embryos (cross section): A - 3 weeks gestation, В - 22 
days, С - 4 weeks; D-G: lateral view of the developing otocyst: D - 414 weeks, E - 514 weeks, F - 6 
weeks, G - 8 + weeks (after Zechner & Altmann, 1979 and Schuknecht & Gulya, 1986) 
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Initial mesodermal induction of inner ear development already starts during 
late gastrulation [van de Water & Represa, 1991], but the first recognizable 
auditory structure, the otic placode, appears as an ectodermal thickening at 
three weeks of gestation. Just before the 4th week, the otic placode 
invaginates into the underlying mesoderm to form the auditory pit. Through 
dilation of this pit and the closing of its surface ectoderm the otocyst is 
formed by the end of the 4th week. Concomitant with the formation of the 
otocyst, the surrounding mesenchymal tissue differentiates into precartilage 
that will eventually form the cartilaginous otic capsule of the otocyst. At 4 to 
5 weeks of gestation, the otocyst starts to develop three major structures: 
the endolymphatic duct and sac, the sacculus and its cochlear duct, and the 
utriculus with its three semicircular canals. This process is completed by the 
end of the eighth week and provides the basis of the vestibular system. At 
the same time the precartilage of the otic capsule becomes true cartilage, a 
process that is coordinated with the differentiation of the adjacent stapes. 
However, dissociation of the cartilage from the otic capsule into loose 
reticular mesenchyme followed by a subsequent ^differentiation occur 
between the 9th and 15th week to allow growth of the otic labyrinth to its 
adult size. During the same time, the cochlear system starts to differentiate, a 
process that is completed by the 25th week of gestation. The ossification of 
the cartilage surrounding the membranous labyrinth is a step-wise process 
that involves at least 14 ossification zones. Ossification starts at the 16th 
week of gestation at the origin of the basal turn of the cochlea and is 
completed shortly before birth. It is also at the beginning of the 16th week 
that histologic differentiation and separation of the stapes from the otic 
capsule becomes apparent. By the 25th week the inner ear has attained adult 
size and configuration and its further development is basically directed 
towards maturation of the structures (e.g. innervation, bone formation, 
establishment of neural connections etc.). 
These developmental processes are controlled by the temporal and spatial 
expression of numerous genes. Recently, Ryan and coworkers [1993] 
postulated 5,000 to 10,000 'luxury' (non-housekeeping) genes to be 
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expressed in the inner ear. Although this may be considered as a high 
estimate, it may reflect the great diversity of tissues that contribute to 
complex structures like the Organ of Corti and the cochlea. During the past 
few years several factors have been identified which are involved in the 
formation and function of inner ear structures [e.g. nuclear receptors for 
retinoic acid and thyroid hormone; Bradley et al, 1994; Dolle et al, 1990], but 
most of the relevant proteins and their respective genes are still unknown. 
Steel [1991] has defined three categories of inner ear defects: (1) 
neuroepithelial anomalies that involve a primary defect in the sensory epithelia 
of the inner ear or its innervation, (2) cochleosaccular abnormalities which 
occur when fluid homeostasis in the inner ear fails, and (3) morphogenetic 
defects that are based on an abnormal course or the premature interruption of 
development. The following paragraphs will focus on the third category since 
this thesis deals with a gene involved in morphological changes of the inner 
ear. 
The homeobox gene Pax-3, which belongs to a multigene family of 
transcription factors, was one of the first genes shown to be involved in 
hearing loss. Epstein and colleagues [1991] reported on a partial deletion of 
this gene in the splotch mouse which shares phenotypic features with 
patients suffering from Waardenburg syndrome (WS). Waardenburg syndrome 
is an autosomal dominant disorder that includes sensorineural deafness and 
pigment disturbances of the iris and the integument, and is frequently 
associated with a white streak of hair on the forelock. Indeed, mutations in 
the human Pax-3 homologue could be demonstrated in patients with 
Waardenburg syndrome type 1 [Tassabehji et al, 1992; Baldwin et al, 1992; 
1994]. It is noteworthy, however, that Pax-3 mutations are dominant in 
humans but recessive or incompletely dominant in mice, and the biochemical 
function of Pax-3 is incompletely understood. In the mouse, dysfunction of 
Pax-3 leads to a dysplasia of neural fold and dorsal neural tube tissue [Moase 
& Trasler, 1990] which is thought to be due to an abnormal regulation of the 
neural cell adhesion molecule (Ncam) gene [Moase & Trasler, 1991] during the 
formation of the otocyst [Goulding et al, 1991]. 
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Another subclass of homeotic genes, the POU-domain genes, have been 
shown to be highly expressed in the developing cochlea [Ryan et al, 1991]. 
This is consistent with the hypothesis that co-expression of specific POU 
domain genes and other homeodomain genes is critical for the maturation of 
different cellular phenotypes [He et al, 1989] but it is also compatible with an 
autonomous action of POU domain genes as transcription factors. 
In 1992, three novel transcription factors have been identified in the otocyst 
of the zebrafish [Ekker et al, 1992]. One of them, dlx-3, probably stimulates a 
particular subset of cells to develop into the otic placode. This process may 
be induced by rendering these cells responsive to inductive signals. Later in 
development, this gene as well as the other two, msh-C and msh-D, are 
believed to exert their role in specifying the fate of distinct cell types [Ekker et 
al, 1992]. Other transcription factors like Hoxa-1 (previously known as 
Hox1.6), c-fos and Pax-2 are also likely to be involved in inner ear 
development of the mouse [Noden 81 van de Water, 1992; Represa et al, 
1990; Nornes et al, 1990]. Indeed, disruption of the Hoxa-1 gene in mice 
resulted in severe inner ear defects [Lufkin et al, 1991]. The small eye 
mutation isey) that is accompanied by early onset deafness in mice has 
recently been identified in the so-called mi gene that encodes a novel basic 
helix-loop-helix leucine zipper transcription factor [Hodgkinson et al, 1993]. 
Transcriptional regulation is a complex process that does not only depend on 
structural parameters of the target gene (DNA binding motifs, conformational 
prerequisites) and the transcription factors themselves, but it is also 
influenced by metabolic changes in the cell. Growth factors are known to 
control these complex signalling cascades which is why they are excellent 
candidates for being involved in developmental processes. Indeed, growth 
factors have been shown to participate in the morphogenesis of the inner ear. 
The transforming growth factor beta, for instance, acts as a primary signal 
molecule that regulates epithelial-mesenchymal tissue interactions involved in 
otic capsule formation [Frenz et al, 1991]. Another example is the 
protooncogene Int2 which codes for a member of the fibroblast growth factor 
family and is thought to induce differentiation of the otic placode into the 
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otocyst [van de Water & Represa, 1991; Mansour et al, 1994]. 
Most of the studies cited above have for a number of practical reasons been 
carried out on mice. Foremost among them is the fact that analysis of the 
development of inner ear defects is not possible in humans. Moreover, genetic 
heterogeneity or allelic mutations in man would complicate interpretation of 
observations from different families. An additional argument in favour of 
choosing the mouse for such studies is that there are numerous mutations 
known which affect the auditory system of the mouse, many of which have 
already been localized in the mouse genome [Lyon & Searle, 1989]. The 
structure and development of the inner ear is basically similar in mammalian 
species. Therefore it seems likely that there is a comparable array of genes 
controlling its development. Analyses of these genes are aided by the strong 
evolutionary conservation of the murine and human genome. Comparison of 
the genetic maps of mouse and human has identified a large number of 
chromosomal regions where both gene content and genetic order are 
conserved [Chromosome Committee Reports of the Mouse, 1993]. As a 
result, the localization of a gene locus in one species can provide strong 
indicators for the chromosomal location of its homologue in the other species 
[Nadeau, 1989]. Therefore, mouse mutations affecting hearing may serve as 
valuable models for hereditary deafness in man. While some mouse mutations 
will simply serve as models for developmental and functional processes, other 
mouse mutations may be true homologues of human hearing disorders. 
Although it is not certain that identical mutations occur in mice and humans, 
understanding how specific genetic mutations affect the auditory system in 
mice will aid the analysis of mutations in the human homologues [Steel, 
1991; Steel & Brown, 1994]. An example is illustrated by the mouse mutant 
shaker-1 (sh-1), for which the underlying defect has been identified in a gene 
on mouse chromosome 7 that encodes a myosin of the type VII family [Brown 
& Steel, 1994; Gibson et al, 1995]. In man, two gene loci involved in 
autosomal recessive deafness have been mapped to the homologous region at 
11q13: NSRD2 (see below) and the gene for Usher syndrome type IB 
[Kimberling et al, 1992]. While mutations in the orthologous myosin VIIA gene 
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have been described for the latter syndrome [Weil et al, 1995], mutation 
analysis of this gene in NSRD2 families has yet to reveal whether the sh-1 
mutant is also an attractive model for this form of non-syndromic deafness 
[Brown & Steel, 1994]. 
The differential screening of tissue-specific cDNA libraries provides another 
strategy to identify genes specifically expressed in the inner ear [Wilcox & 
Fex, 1992; Ryan et al, 1993; Robertson et al, 1994; Davis et al, 1995]. 
Likewise, cDNA libraries from different developmental stages can be employed 
in order to select transcripts specifically expressed during development. The 
characterization of genes from such libraries will improve our understanding of 
the mechanisms underlying the development and functioning of the inner ear 
and should provide new insights into the aetiology of hearing defects. 
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1.4. Genetic forms of deafness in man 
Deafness is a common cause of disability in our population. As the known 
environmental causes of hearing impairment (e.g. meningitis, kernicterus, 
prenatal virus infections), have been minimized, genetic forms of deafness 
have become relatively more important. At least half of the severe forms of 
childhood deafness can be attributed to genetic causes [Rose et al 1977] 
which corresponds to an incidence of 1 in 2000. However, these figures 
probably do not reflect the true prevalence of genetic deafness in man, 
because most available data are derived from studies of congenital and 
prelingual hearing disorders. Hearing impairment of later onset is also likely to 
be influenced by genetic factors. Davis [1989] proposed that 15-20% of the 
population is significantly hearing impaired. According to the studies of Corey 
and Breakefield [1994] even a third of us will suffer from substantial hearing 
loss by old age. 
While in approximately 30% of cases genetic deafness is accompanied by 
other clinical features (e.g. Usher syndrome, Waardenburg syndrome), the 
remaining 70% display a non-syndromal phenotype [Bergstrom et al, 1971]. 
The vast majority of genetic deafness (>75%) is inherited in an autosomal 
recessive fashion [Rose et al, 1977]. Recently, three genes for autosomal 
recessive, neurosensory hearing loss have been mapped: NSRD1 (DFNB1) to 
the 13q12 region [Guilford et al, 1994a], NSRD2 (DFNB2) to 11q13.5 
[Guilford et al, 1994b], and NARDI {DFNB3) has been assigned to the 
pericentromeric region of chromosome 17 [Friedman et al, 1995]. Linkage 
analyses have also localized three genes involved in dominant, non-syndromal 
sensorineural deafness; one gene (DFNA1) has been assigned to 5q31 [Leon 
et al, 1992], another to the short arm of chromosome 1 [Coucke et al, 1994], 
and the third gene has been found to co-localize with the NSRD1 locus on 
chromosome 13q12 [Chaïb et al, 1994]. Autosomal dominant deafness 
comprises 10-20% of the cases [Rose et al 1977], and another 2-3% can be 
attributed to mutations of X-chromosomal genes [Fraser 1976]. 
There is also a small number of cases caused by alterations in the 
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mitochondrial (mt) DNA. Mitochondrially inherited deafness usually occurs as 
part of a multi-systemic disorder [e.g. Kearns-Sayre syndrome; Swift & Singh, 
1988]. Ballinger [1993] reported on a family with maternally inherited 
diabetes and deafness caused by mtDNA rearrangements including 
duplications and deletions. Interestingly, similar rearrangements have been 
described in patients with Kearns-Sayre syndrome, but not in chronic 
progressive external ophthalmoplegia (CPEO), a mitochondrial disorder without 
hearing loss [Poulton et al, 1994]. In addition, two point mutations in the 
mitochondrial DNA have been described that appear to predispose to isolated 
sensorineural deafness [Prezant et al, 1993; Reid et al, 1994]. 
X-chromosomally inherited deafness is clinically heterogenous. Some types, 
however, can easily be distinguished as they occur in association with other 
features as part of a syndrome (for review, see Brunner et al, 1991). Hearing 
loss in some of these syndromes is not a consistent feature but can be 
recognized frequently, as has been reported for Norrie disease, Alport 
syndrome and X-linked Charcot-Marie-Tooth disease [Warburg, 1966; Barker 
et al, 1990; Cowchock et al, 1985]. This can be explained by several 
mechanisms including variable expression, pleiotropic effects, allelic mutations 
in a single gene, non-allelic heterogeneity, or as a CGS. However, the latter 
possibility already has been excluded in Norrie disease and Alport syndrome 
[W. Berger, personal communication; Barker et al, 1990]. 
X-linked, non-syndromic deafness has been classified into four clinical entities 
based on audiologic features and the age of onset: (1) early onset 
sensorineural type, (2) congenital sensorineural type (DFN2 in McKusick's 
catalogue), (3) moderate sensorineural type, and (4) early onset, progressive 
mixed hearing loss with congenital fixation of the stapedial footplate giving 
rise to the perilymphatic 'gusher' phenomenon at stapes surgery (DFN3 in 
McKusick's catalogue) [Konigsmark & Gorlin, 1976; McKusick, 1990]. 
However, there is evidence that this classification is not in agreement with 
the genetic categories of X-linked deafness. Glasscock [1973] and Cremers 
[1985] reported on male probands with mixed hearing loss of the DFN3 type 
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in whom the sensorineural component had progressed notably, thereby 
increasingly 'masking' the conductive element. Therefore, it is tempting to 
speculate that some of the cases with apparently 'pure' sensorineural 
deafness are due to mutations in the OFN3 gene. 
Thorough clinical characterization of males with X-linked deafness has 
revealed several distinguishing features that are of use for differential 
diagnosis [e.g., see Cremers et al, 1985; Reardon et al, 1993]. By employing 
high resolution computerized tomography (CT), it has proved possible to 
distinguish affected males with normal inner ear structures from probands 
who exhibit distinct changes of the temporal bone, the latter being a 
characteristic feature of DFN3. In the inner ear of these patients, the most 
conspicuous finding is the bulbous internal auditory canal (IAC) with an 
incomplete bony separation from the basal coil of the cochlea (Fig. 2) [Michel 
et al, 1991; Phelps et al, 1991]. 
I COCHLEAR AQUEDUCT 
Figure 2: Schematic presentation of the primary lesion in the inner ear of DFN3-affected patients. 
The abnormally wide communication between the subarachnoid space of the internal auditory canal 
(IAC) and the perilymphatic space in the cochlea leads to a perilymphatic-cerebrospinal fluid hydrops in 
the vestibule. Upon surgical mobilization of the stapedial footplate, this hydrops results in a profound 
gusher. EAC - external auditory canal; ST - scala tympani; SV - scala vestibuh (after Schuknecht & 
Reisser, 1988) 
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However, these radiological findings are not correlated with the audiological 
features [Reardon et al, 1993]. In the pedigrees studied it became apparent 
that both abnormal and inconspicuous CT-scans can be associated with mixed 
as well as sensorineural hearing loss. In contrast, it appears that the 
anatomical findings do correlate with the vestibular function. All males with 
anatomical changes of the inner ear show abnormal or deficient vestibular 
function whereas almost all of the probands with a normal temporal bone also 
have regular vestibular function [Reardon et al, 1993]. 
The correlation between anatomical findings and the quality of the stapedial 
reflexes is less clear. Reardon and coworkers [1993] reported on the absence 
of stapedial reflexes in all males with abnormal anatomy of the inner ear, but 
they also found probands with normal inner ear structures lacking stapedial 
reflexes. On the other hand, Cremers [1985] described patients with gusher-
related deafness and abnormal inner ear structures, showing very pronounced 
stapedial reflexes. This could mean that even patients with the same 
anatomical changes of the inner ear are genetically heterogenous or that the 
stapedial reflex is a poor diagnostic parameter for the classification of inner 
ear anomalies. 
It has been suggested that areflexia of the stapes is due to impaired stapes 
mobility [Reardon et al, 1993]. A primary fixation of the stapes, that is caused 
by defective differentiation of the peripheral lamina stapedialis into the annular 
ligament [Olson & Lehman, 1968], was proposed to be indicative for X-linked 
mixed deafness (DFN3) [Nance et al, 1971]. Primary stapes fixation, however, 
has not consistently been observed in patients with perilymphatic gusher 
during ear surgery [Glasscock et al, 1973; Bento et al, 1985]. Brown-Farrier & 
Endicott [1971] put forward the hypothesis that impaired stapes mobility is 
caused by a 'perilymphatic fluid hydrops' in the vestibulum. Upon surgery, the 
increased pressure is responsible for a pouring rush of perilymphatic fluid, i.e. 
the so-called 'gusher'. In fact, only the first few millilitres are true perilymph 
whereas the remainder is cerebrospinal fluid (CSF) [Schuknecht & Reisser, 
1988]. It has been assumed that an abnormally wide cochlear aqueduct is 
responsible for this phenomenon [Brown-Farrior & Endicott, 1971]. However, 
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anatomical measurements revealed that enlarged aqueducts can at most 
account for 'oozers' (i.e. a milder welling-type of flow) but not for gushers 
[Schuknecht & Reisser, 1988]. The same authors suggested that a bony 
defect in the fundus of the IAC causes the abnormally wide communication 
between the cerebrospinal fluid of the subarachnoid space and the perilymph 
in the cochlea. This concept has been corroborated by radiologic studies that 
have revealed the predicted temporal bone anomalies in the inner ear of 
affected males [Jensen et al, 1977; Cremers et al, 1985; Michel et al, 1991; 
Phelps et al, 1991]. Against this background, the stapes fixation in X-linked 
mixed deafness (DFN3) probably relates more closely to the anatomical 
anomalies of the inner ear rather than to primary stapes pathology [Reardon et 
al, 1993]. 
Independent evidence for heterogeneity of non-syndromic X-linked deafness 
has come from molecular studies. Initial linkage studies in pedigrees with 
DFN3 suggested a single locus in Xq13-q21 for this condition [Brunner et al, 
1988; Wallis et al, 1988, Robinson et al, 1992]. A multi-pedigree study 
corroborated this localization and provided evidence for at least one other X-
chromosomal form of sensorineural deafness [Reardon et al, 1992a]. Lalwani 
and coworkers [1994] were able to substantiate the latter finding when 
mapping a gene for X-linked sensorineural deafness to Xp11.3-p21.1. 
Recently, linkage analysis has revealed the existence of a third X-
chromosomal deafness gene [Bitner-Glindzicz et al, 1994]. Interestingly, 
deafness associated with anatomical changes was consistently mapped to the 
Xq21 region [Reardon et al, 1992a,b; Robinson et al, 1992], suggesting that 
this form of deafness represents a distinct genetic entity. 
Recently, VoFechovsky and coworkers [1995] have cloned a gene 
(DXS1274E) from Xq22 that is partially deleted in a patient with X-linked 
agammaglobulinaemia (XLA), torsion dystonia and sensorineural deafness. 
Provided that the complex phenotype in this patient is due to a CGS, 
DXS1274E is another candidate gene for X-linked, non-syndromic hearing 
loss. Mutation analysis for this gene in patients with isolated, X-linked 
sensorineural hearing loss should soon clarify this matter. 
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At present, it may be too early for a comprehensive classification of non-
syndromic X-linked deafness. The identification and characterization of genes 
involved in the aetiology of non-syndromic X-linked deafness will provide 
more insight into the relationship between clinical findings and the genetic 
basis of this trait. 
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1.5. Outline of this study 
The aim of this study was to map the DFN3 gene locus and subsequently to 
characterize the chromosomal region around this locus. Analogous to the 
studies that led to the localization and cloning of the CHM gene [Cremers et 
al, 1991], patients with syndromic and classical X-linked deafness were 
characterized at the molecular level in order to define the physical limits of the 
critical region carrying the DFN3 locus [chapters 2, 3 and 4] . To this end, a 
systematic search for novel genetic markers in the proximal Xq region was 
performed and YAC libraries were screened to cover the entire critical region. 
Subcloning and characterization of some of these YACs allowed the precise 
mapping of the recently described DFN3-associated deletions, as well as the 
identification of novel submicroscopic deletions in patients with non-
syndromic DFN3 [chapter 5]. In this way, the DFN3 gene was assigned to a 
500-kb interval. Attempts to isolate expressed sequences from this interval by 
cDNA hybridization and other techniques were not successful. Instead, a POU 
domain gene, P0U3F4, previously mapped to an evolutionary homologous 
segment on the murine X-chromosome [Douville et al, 1994], turned out to be 
a promising candidate gene for this type of non-syndromic deafness because 
it is expressed in the inner ear. Strong support for a causal role of P0U3F4 in 
DFN3 has come from subtle point mutations that have been detected in 
several patients with X-linked deafness and temporal bone defects [chapter 
6]. 
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DNA probe screening of somatic cell hybrid· derived 
from females with X; autosome translocation· has en­
abled ns to define eight new breakpoints within the 
Xql3—q22 region. Together with other X-chromosome 
rearrangements that have been described earlier, these 
breakpoints subdivide the Xq21—q22 region into 2 0 in­
tervals. Our panel refines the physical assignment of 
4 0 probes in the Xq21-q22 segment. Thus, these X-
chromosome rearrangements are useful tools for order­
ing X-linked markers and genes on the proximal long 
arm of the human X chromosome, e i n s 
INTRODUCTION 
Physical mapping of the human X chromosome for a 
long time relied on the molecular characterization of de­
letions and X; autosome translocations, the former of 
which were found almost exclusively in bands p22.3 
(STS, Kallmann syndrome), p21 (DMD), and q21 
(CHM). The availability of an increasing number of 
DNA markers and the introduction of YAC technology 
have resulted in the construction of YAC contigs span­
ning approximately 40% of the human X chromosome 
(Mandel et oL, 1992). 
During the past 3 years, we (S.G. and co-workers) 
have collected eight cases of female patient carriers of 
X; autosome translocations (t(X; A) ) with the X-chromo-
somal breakpoint located in the q proximal region. In 
seven of these patients, clinical features include gonadal 
dysgenesis and, in two cases, clinical findings were sug­
gestive of defined X-linked disorders: TDo, a female 
with a balanced t(X;7)(q21;ql3;pl2) translocation (Ka­
plan et cd., 1989), had characteristic signs of choroidere-
mia, and PMI, a girl with a t(X;13)(ql3;q34), was mark­
edly mentally retarded (Téboul et aL, 1989). 
In the present report, these eight X-chromosomal 
breakpoints are precisely assigned in the ql3-q22 region 
by using molecular and somatic cell genetic approaches. 
1
 To whom cornapondance should be addressed. Telephone- (33) 83 
44 62 62. 
In this way, closely linked probes have been identified on 
either side of the translocation breakpoints. The corre-
lation between the localization of the different X-chro-
mosomal breakpoints and the resulting phenotypes in 
these female patients is discussed. 
As part of the studies of genes that map to the Xq21 
band (the CHM gene, the DFN3 gene, and a gene for 
MRX), we (Hilger Ropers and co-workers) have charac-
terized a large number of X rearrangements in the q 
proximal region (Cremers et aL, 1988,1990a; Bach et aL, 
1992a,b). By combining these X rearrangements with 
the X-chromosomal breakpoints reported here, we were 
able to construct a physical mapping panel that consists 
of 26 X-chromosome rearrangements and defines 20 in-
tervals inside the q21-q22.1 region. This mapping panel 
will be a useful tool for ordering X-linked markers and 
genes on the proximal long arm of the human X chromo-
some and should facilitate positional cloning of genes 
underlying deafness (DFN3) and nonspecific mental re-
tardation (MRX) 
MATERIALS AND METHODS 
We present the cytogenetic and molecular findings ш eight patients 
investigated m. this study (PMI, C56N, TDo, WD, LG, FA, ВС, and 
SN) For the other cases, the clinical and cytogenetic data as well as 
Southern blot analysis of the rearranged X chromosomes has been 
described elsewhere, i.e., CN, KM, NP, and RvD (Cremers et αϊ, 1988, 
1989a), XL62, DM. XL45, MBU, and HR10 (Cremers et el, 1989а), 
1/10 and ТО (Bach et aL. 1992а); SD and D20 (Bach et al. 1992b), 
LGL2905, 3.5, 7 6, 25 6. and 33.1 (Cremers et al, 1990а), С1П-1 
(Cremen et aL, 1989b, 1990b). 
Clinical and cytogenetic data. Karyotypes and phenotypes from 
the patients an shown ш Table 1 Lymphoblastom cell lines wen 
established from peripheral blood using Epstein-Ватт virus (EBV) 
according to standard methods. 
Construction of somatic cell hybrids. Somatic cell hybrid» between 
hamster RJK88 cells (Fuscoe et aL, 1983) and lymphoblastoid cell 
lines wen obtained with PEG according to the procedure described by 
Pontecorvo (1975) 
Southern blot analysis. DNA was extracted from the lymphoblas­
toid cell lines and from the derived hybrid clones according to the 
method described by Jeanpiern (1987) Methods for Southern blot 
analysis have been published previously (Cremen et aL, 1988) 
Screening of hybrid cisnes. To refine the cytogenetic localization 
of the X breakpoints using Southern blot analysis, we have used so-
0888-7543/93*5 00 
Copyright С 1993 by Ararhmir Prêta. Inc. 
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T A B L E 1 
Cytogenet ic a n d Cl in ical F e a t u r e · 
other human autosomes in the hybrid cell lines has not been investi-
Patient 
ВС 
FA 
LG 
PMI 
SN 
TDo 
WD 
C56N 
Cytogenetic 
examination 
46\X,t(X;12)<q21;pl3) 
46,X,t(X;15)(q21;q26) 
46,X,t(X3)(q21;q33) 
46
r
X,«X;13)(ql3;q31) 
46,X,t№9)(q22;q22) 
46\X,tCfc7)<q21;pl2) 
4β,Χ,«Χ2)(α21;ρ25) 
46,X,t(X£)<q21;qll) 
Clinical features 
Secondary amenorrhoea 
Secondary amenorrhoea 
Secondary amenorrhoea, aligilt 
mental retardation 
Mental retardation, scoliosis, 
skin pigmentation 
disturbance 
Primary amenorrhoea 
Primary amenorrhoea, 
cboroideremia 
Primary amenorrhoea 
Amenorrhoea 
marie cell hybridization to isolate the der(A) bearing the Xq21-qter 
region. A preliminary •*•***"«"g was necessary to confirm both the 
presence of the der(A) and the absence of the normal X and the 
der(X). Thus, the X-chromosome content of hybrid clones was deter­
mined by scoring for Xp and Xq probes. XJ1.2 (DXS206) and RX-97 
(DXS348), located at Xp21.1 and Xql2-ql3.1, respectively, are proxi­
mal to the X breakpoints, whereas FVffi (F8c) and S t i v i (DXS52), 
located at Xq2S, are distaL The HAT-selected clones that gave the 
appropriate signals after Southern blot analysis (a signal with Stl4-1 
and FVin and no signal with XJ1-2 and RX-97), suggesting retention 
of the der(A) but not the der(X) and the normal X, were used for the 
suitable DNA " " ^ — trom the j>nnini»l Xq region. The presence of 
DNA markers. Information concerning most of the DNA probes 
used in this study can be found in the report of the committee on the 
genetic constitution of the X chromosome (Devies et aL, 1991). Probe 
pXG8b was provided by P. Szabo; pFl and pFS were gifts from T. A. 
Kruse (Aaxhus). Probes 1:52, 2:30, 2.-6, 2:63, 2.-93, 3:29. 3:49, and 3:7 
were provided by R. P. Kandpal (New-Haven, CT); CR39 (Clarke et 
aL, 1987) was provided by P. Edwards (Los Angeles, CA), рІОЭ by I. 
Wieland (Essen, FRG), CMPXl (ZNF6) by С. A. Sargent (Cam­
bridge, UK). CR3 by M. G. Persico (Napoli, Italy), and DXYS42 by 
L. G. Brown (Cambridge, MA). Probes trom the X-Y homologous 
region, 13d, GMGXY5, GMGXY6, GMGXY8, and GMGXY9, were 
gifts from N. A. Affare. 
RESULTS 
Characterization of X Breakpoints in Females with 
KX.A) 
In the eight females with balanced X; autosome trans­
locations studied, the breakpoints on the X had been 
localized cytogenetically in the ql3-q22 interval (the 
karyotypes and phenotypes of these individuals are de­
scribed in Table 1). In each case, X-inactivation studies 
showed a nonrandom pattern of inactivation: the nor­
mal X was late replicating in all cells, as is the rule in 
females with balanced X; autosome translocations 
(Mattei et al, 1982). In all of these cases but one (PMI), 
gonadal dysgenesis was observed. In addition, patient 
TDo suffers from choroideremia, and PMI is mentally 
retarded. 
0XS111 
1:52 
FIG. 1. Molecular localization of X-chromosomal breakpoints in the q proximal region according to DNA marken. The order of probes 
within each interval is arbitrary. 
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TABLE 2 
Results of Hybridization Experiments 
Loo» Probe 
Hybrid cell line 
PMI 
ell 
C56N 
ell 
TDo 
el l 
WD 
ellO 
LG 
СІ4 
FA 
cl 2 
ВС 
cl 2 
SN 
cil 
DXS153 
DXS132 
DXS135 
PGKPl 
DXS159 
DXS131 
DXS12S 
XIST 
DXS171 
PGK1 
DXS56 
DXS227 
DXS72 
DXS26 
DXS232 
DXS121 
DXS165 
DXSS40 
DXS95 
DXS110 
— 
DXYS1 
DXYS 5X 
DXYS7X 
DXYS 31X 
DXYS 32X 
DXYS 34X 
DXYS 35X 
DXYS 13X 
DXS214 
DXYS 12X 
DXS3 
DXS112 
DXS73 
DXS87 
DXS96 
DXS118 
— 
— 
DXS211 
DXS94 
DXS17 
DXS111 
CX37.1 
cpX23 
cpX93 
pHPGK-7e 
cpX289 
cpX21 
cX65.3 
pGlaX2.2 
срХбЗ.с 
pHPGK-7e 
pL2.98 
plbB4 
pX65H7 
pHUl6 
pJL68 
p784 
plbD5 
pZllc 
pXG7.c 
p722 
pXGSb 
pDP34 
p47b 
13d 
GMGXY5 
GMGXY6 
GMGXY8 
GMGXY9 
pTAK2 
pPA20 
p3t25.2 
РІ9.2 
p753 
pX20R42 
рЛІЗШ 
рХбЗ.Ь 
p776 
pFl 
pF8 
pD3 
pXG12 
pS9 
p733 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Note. A + indicates that the hybridization signal detected by the probe is present in the DNA from the hybrid clone (ell, clone one; cl2, clone 
two,. . .). A — indicates that the hybridization signal is absent. 
To refine the localization of these X breakpoints, 
Southern blot analysis with 42 Xq proximal probes was 
performed (the data obtained are summarized in Table 2 
and depicted in Fig. 1). 
The finding of a balanced translocation (X;7)(q21; 
pl2) associated with choroideremia, an X-linked reces­
sive disorder, in female TDo strongly suggests that the X 
breakpoint disrupts the CHM gene. The localization of 
the X breakpoint between p784 (DXS121) and p722 
(DXS110) is in agreement with the previous assignment 
of the CHM gene (Cremers et aL, 1989a, 1990a). Re­
cently, a part of the gene for choroideremia has been 
isolated by making use of positional cloning strategies 
(Cremers et aL, 1990b). Neither pZl lc (DXS540), an in-
tronic clone located in the middle part of the CHM gene, 
nor pTHO, a CHM cDNA probe corresponding to the 
central and 3' portion of the gene, is present in the hy­
brid cell lines derived from patient TDo. Probe pTHO 
detects five human EcoRl bands from Xqter to Xcen: 
7.5, 4.5, 12.5, 2.6, and 4 kb (in addition, three EcoRl 
bands are detected in the rodent genome). None of the 
human bands is present in the hybrid cell lines derived 
from patient TDo. From these data, we conclude that 
the X breakpoint in this patient with choroideremia is 
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Ну 
ТОО 
с и C¡1 
Ну -, 
TDdTDdWK 
"У 
СО 
m 
m 
** -іг.экь 
-7.5 to 
-4SW3 
pZ11C ртію 
срХ289 срХ21 
FIG. 2. Characterization of the X breakpoint« in female TDo 
with probes pZllc (DXS540) and pTHO (CHM) and in female PMI 
with probes cpX289 (DXS159) and cpX21 (DXS131). Southern blot 
analysis of £coRI-digested DNA. TDo: parental lymphoblastoid cell 
Une TDo; Ну TDo CL1, Ну TDo C13: hybrid clones 1 and 3 derived 
from the parental cell line TDo; PMI: parental lymphoblastoid cell 
line; Ну PMI СП: hybrid clone 1 derived from the parental cell line 
PMI; RJK 88: rodent cell line used for interspecific hybridization. 
located in the distal part (i.e., the 5' end) of the CHM 
gene, which has not yet been cloned. 
The translocation breakpoint of PMI, which had been 
cytogenetically localized to Xq21 (Téboul etaL, 1989), is 
located distal to cpX289 (DXS159) (Fig. 2c) and proxi-
mal to cpX21 (DXS131) (Fig. 2d). Both DXS162 and 
DXS131 have been mapped previously by Lafreniere et 
al (1991) between two X-chromosomal breakpoints that 
are located in band Xql3.1, suggesting that our previous 
cytogenetic assignment of the PMI breakpoint was erro-
neous. Indeed, cytogenetic reexamination has shown 
that the X-chromosomal breakpoint in this patient is 
located in the ql3.1 band. Given the fact that PMI is 
markedly mentally retarded, this may indicate that the 
translocation in this patient has disrupted one of the 
several genes involved in nonspecific mental retardation 
(MRX) that are known to be located on the proximal Xq 
(Davies et al, 1991; Glass, 1991; Neri et aL, 1992). 
Regional Mapping of X Probes 
Our panel of eight X-chromosomal breakpoints, 
which defines nine distinct physical intervals on the 
proximal long arm of the human X chromosome, was 
used to regionally assign X-chromosomal probes previ-
ously mapped to the pericentromeric region of the X 
(Table 3). Ten probes were hybridized to the hybrid 
panel. Figure 1 shows the localization of these probes in 
relation to the different X breakpoints. 
A Physical Mapping Panel of the Xq21-q22 Region 
When combined with previously described X-chromo-
somal rearrangements in the vicinity of the CHM locus, 
the translocation breakpoints described here define 20 
intervals in the Xq21-q22 region (see Fig. 3). 
DISCUSSION 
This report describes the characterization of a set of 
eight t(X;A) translocations in females. Hybridization 
experiments with Xq probes allowed us to precisely local-
ize the X-chromosomal breakpoints in the Xql3.1 to 
Xq22 segment and to dissect this region into nine inter-
vals. Our physical mapping data are consistent with the 
current consensus map (Davies et al, 1991). This panel 
was subsequently used to improve the localization of 
probes from the pericentromeric region of the X chro-
mosome. Numerous probes flanking the respective X-
chromosomal breakpoints allowed us to assess the pres-
ence and integrity of the X-chromosomal portion of the 
der(A), although tiny rearrangements in the hybrids 
could not be firmly excluded. 
In all female patients but one, the X; autosome trans-
location is associated with ovarian dysgenesis. These re-
sults are in agreement with the concept that the X q l 3 -
q26 region must be present and intact to allow normal 
ovarian development and function (Sarto et al, 1973; 
Thermen et aL, 1990). 
Several disease loci have been mapped precisely 
through the study of females with X; autosome translo-
cations that were associated with X-linked diseases (Da-
іев et aL, 1991). As first proposed for girls with balanced 
X; autosome translocations and full-blown Duchenne 
muscular dystrophy (Greenstein et al., 1977; Verellen et 
aL, 1977), clinical symptoms in these cases can be ex-
TABLE3 
Improvement of the Localization of 10 X Probes Using 
a Panel of β X Breakpoints 
Probe designation 
(locus symbol) 
Regional assignment 
Before this study This study 
CR39 (CHR39C) 
pl09 
2:3, 2:93 
2:6, 2:63, 3:29, 3:49,3:7 
1:52 
Xql3-q21' 
X' 
Xpll.2-q21.3* 
Xpll.2-q21.3* 
Xpll.2-q21.3· 
XqlS.l 
Xpter-ql3.1 
Xpll.2-ql3.1 
Xpll.2-q21.1 
Xq22-qter 
• Davies et aL (1991). 
'WieUndetol (1992). 
'Arenstorf etat (1991). 
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de 
de 
de 
de 
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de 
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de 
de 
» 
ff 
ff 
ff 
ff 
ff 
» 
ff 
Sfi 
Sfi 
• Sfi 
Sfi 
6 
г 2 
6 
3 
6 
3 
а 6 
β 
β 
β 
β 
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• 
• 
• 
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FIG. 3 . Physical mapping panel of the Xq21-q22 region generated by integrating data presented in this study ( · ) and elsewhere. At the top 
an idiogram of the Xq21-q22 region in G-banding is presented. The segment of the X chromosome present in cell lines is indicated by a single 
line for translocations (tx) and deletions (de); a double line indicates the duplicated region in the cases of a duplication (du). In the lower part of 
the figure the regional location of 40 DNA marken in 20 subrogions of the Xq21-q22 region is shown. At the right side, the respective references 
are indicated. 
plained by the disruption of the respective disease gene 
on the rearranged X chromosome and by preferential 
inactivation of the (gene on the) normal X chromosome. 
In our present study, clinical symptoms in at least two of 
eight females studied may also be due to the disruption 
of specific genes. First, the X-chromosomal breakpoint 
in patient TDo, who is affected by choroideremia, maps 
distal to the most telomeric portion of the CHM gene 
that is currently known (Cremers et aL, 1990b); thus, 
chromosome breakage in this patient may affect the pro­
moter region of this gene. Cloning of the 5' end of the 
CHM gene, which is in progress, and further molecular 
characterization of this breakpoint should soon clarify 
this point. Similarly, molecular characterization of the 
X-chromosomal breakpoint in patient PMI could be an 
important step toward the cloning of one of the genes 
underlyingX-linkedmental retardation. Further charac­
terization of this X-chromosomal breakpoint using radi­
ation-reduced cell hybrids and YAC technology is in pro-
Recently, Lafreniere et aL (1991) reported a physical 
mapping panel that provided a very detailed map for the 
Xpll.3-ql3.3 region with no less than 12 X breakpoints. 
Here, we have extended these studies and established a 
physical mapping panel for the Xq21-q22.1 region. 
Since, in the Xq21-q22.1 region, this mapping panel is 
estimated to contain 1 breakpoint per megabase of 
DNA, it provides an excellent framework for the con­
struction of a YAC contig of this chromosomal region 
and for the isolation of disease genes located therein. 
DNA samples from the panel of hybrids described in this 
study, and individual hybrid cell Unes, are available 
upon request. 
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Summary. Linkage studies and cytogenetically visible 
deletions associated with nonspecific X-linked mental 
retardation (XLMR) and a specific form of deafness 
(DFN3) have indicated that the genes responsible for 
these disorders are located at Xq21. Using D N A probes 
from this region, we have studied several overlapping 
deletions spanning different parts of Xq21. I b i s has 
enabled as to assign the DFN3 gene and a gene for non­
specific XLMR to an interval that encompasses the locus 
DXS232 and that is flanked by DXS26 and DXS121. 
Introduction 
Microscopically visible male-viable deletions are clus­
tered in three regions of the human X-chromosome, i.e. 
band Xp22.3, band Xp21 carrying the gene for Duchenne 
muscular dystrophy and band Xq21 on the proximal long 
arm. Most of the Xq21-deletions give rise to a complex 
phenotype including choroideremia (CHM), mental re­
tardation (MR), and deafness (Tabor et al. 1983; Hodg­
son et al. 1987; Nussbaum et al. 1987; Rosenberg et al. 
1987; Wells et al. 1991). 
Evidence that several independent loci are involved 
in these complex syndromes has come from linkage 
studies. A gene responsible for progressive mixed deaf­
ness with stapes fixation and perilymphatic gusher dur­
ing stapes surgery (DFN3, МГМ 304400) was mapped by 
different groups to the Xql3-q21 region (Brunner et al. 
1988; Wallis et al. 1988; Reardon et al. 1991). At least 
one locus for non-fragile X nonspecific X-linked mental 
retardation [non fra(X)-XLMR] could be assigned to 
proximal Xq by means of linkage studies in different 
families (Arveiler et al. 1988; Sutherland et al. 1988; 
Stevenson et al. 1991). The CHM gene was mapped to 
Xq21 by means of linkage studies, translocations and 
deletions (Davies et al. 1987; Cremers et al. 1989a, b ; 
Merry et al. 1989). Physical characterization of these 
deletions allowed the fine mapping of the CHM locus 
within the Xq21-band and paved the way for the cloning 
Correspondence to: I.Bach 
of this gene (Cremers et al. 1990b). Simultaneously, 
these studies indicated that the relevant deafness and 
XLMR genes are located proximal to CHM (Cremers et 
al. 1989b). 
Here, we report molecular studies of additional over­
lapping deletions, two of which are associated with a 
complex phenotype, including deafness and mental re­
tardation. This has enabled us to refine the localization 
of the DFN3 gene and the gene for non-specific XLMR. 
Materials and methods 
Patients 
The clinical and cytogenetic data of the patients are listed in Table 1. 
Southern bloc analysis 
Chromosomal DNA from peripheral blood and Epstein-Ban virus 
immortalized B-cells was isolated by standard methods (Miller et 
al. 1988) and digested with the appropriate enzymes (Biolabs, 
BRL) according to the instructions of the manufacturer. After 
separation of DNA fragments by gel electrophoresis (0.8%" Seakem 
agarose, FMC), blotting onto GeneScreen Plus membranes 
(NEN) was performed either using an alkaline Southern transfer 
(Sambrook et al. 1989) or an alternative "dry blot transfer''. The 
latter method is performed in the same way as the standard South­
ern blotting procedure except for the omission of transfer buffer. 
The gel is placed directly onto a glass plate and is covered with the 
nylon membrane, 3 sheets of Whatman 3MM (soaked in 0-5 Ai 
NaOH/l.SM NaCl) and several layers of disposable tissues. 
Radioactive probes were prepared according to Feinberg and 
Vogelstein (1983) by random oligonucleotide priming of DNA 
inserts resolved in and isolated from Iow-gelHng-temperatare 
agarose. Probes containing repetitive sequences (pX104f, pFl and 
pF8) were pre-assoäated with sonicated human DNA as published 
elsewhere (Litt and White 1985). (Pre)hybridization and washing 
procedures were performed by standard methods (Sambrook et al. 
1989). 
DNA markers 
The anonymous DNA markers from Xq21 used in this study have 
been described previously (Goodfellow et al. 198S; Nussbaum et 
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Table 1. Clinica] and cytogenetic data of patients studied 
Panent Age 
(years) 
Clinical features Cytogenetic examination Reference 
LGL290S 
MBU 
25.6 
33.1 
35 
гас 
SD* 
37 
-35 
38 
43 
31 
2 
9 
CHM 
СНМ, seizures, (MR) 
CHM 
CHM 
CHM 
Retinal abnormalities, mixed 
deafness, seizures, MR 
Rebnal pimnentary cbsturbances, 
sensorineural deafness, urinary 
Not investigated (m) 
46,Y,del(X)q21) 
approximately 50% 
m 
Ш 
46.XY 
46,Y,del(X)(q21.1-q21.2) 
46,Y,del(X)(q21) 
only part of Xq21 
DM 
ХЫ5 
XL62 
26 
40 
18 
NP 11 
abnormalities, delayed mental 
development 
CHM, MR, profound sensorineural 
deafness, myopia, epilepsy 
CHM, MR, profound sensorineural 
deafness, obesity 
CHM, MR, moderately severe, mixed 
deafness with stapes fníauon and 
perilymphatic gusher, short stature 
CHM, MR, deft bp and palate, 
hypertelorism, microcephaly, 
agenesis of the corpus callosum 
46,Y,del(X)(q21 l-q21 3) 
46,Y,del(X)(q21) 
approximately 50% 
46,Y,del(X)(q21) 
46,Y,del(X)(q21 l-q21 33) 
Sankdaetal (1990) 
Hodgson et al (1987) 
Merry et al (1989) 
F Brunsmann, personal communication 
F. Brunsmann, personal communication 
F Brunsmann, personal commumcation 
Wells et al. (1991) 
D. Robins, personal communication 
Reardon et al. (1992) 
Rosenberg et al (1987) 
Schwartz et al (1988) 
Ayaaetal (1981) 
Nussbaumetal (1987) 
Nussbaumetal (1987) 
Tabor et al (1983) 
Rosenberg et al (1986) 
* Too young to show the characteristics of CHM 
choroid« renia 
choroìdaremia 
mental retardation 
|CLP 
ого 
LGL Э.С 
2 9 0 S MBU 25 β ЭЭ.1 SD 
XL62 
XL45 NP 
Xq 
0XS72 
Dxsisa 
ожег« 
Dxa»3 
0XS121 
Dxsasa 
Dxsia« 
CHM 
oxaas 
orano 
DXYS12 
D x s i i a 
oxaa 
DXS7S 
oxea· 
OX811B 
«xesHr 
0X1041 
pHuia 
P7S4 
PJLS 
p i ьов 
p486 
рХ Ге 
р г г г 
рхоаь 
РОРЭ4 
р47Ъ/рЭ1 
p m z o 
раігб-2 
p7sa 
p1fl 2 
РХ20Я42 
pXOSb 
p77« 
pFS 
pF1 
1 
2 
3 
4 
5 
6 
7 
• 
e 
• 
I 
η 
• 
e 
а 
b 
Fig. 1. Deletion map of the Xq21-region. 
Deleted segments are indicated by vertical 
¡mes The horizontal bar represents the 
DFN3/XLMR region Probe order for 
intervals б and 7 are arbitrary except for 
probes pX20R42 (DXS73) and pFl, which 
have been positioned employing an 
X/autosome-nanslocation panel 
(C Philippe, personal communication) 
The intervals and ЬяпНщд pattern of this 
chromosomal fragment are not drawn to 
scale Panents SD and D20 are included in 
the group of CHM patients because then" 
ophthalmological findings are consistent 
with the pre-status of choroideremia. 
CLP, Cleft lip and palate 
al. 1987, Cremen et al 1990a; Santola et al. 1990). Probe p496 
(CHM) corresponds to the cloned cDNA of the choroideremia 
gene (Cremers et aL 1990b). 
Results 
Two recently identified large deletions (Wells et al 
1991; Reardon et al. 1992) were tested with all relevant 
probes from the Xq21-region, including a new anonym­
ous marker from interval 2, pHU16 (DXS26) (Sankfla et 
al. 1990) Based on previous mapping data and the re­
sults presented m this study, we could divide the previ­
ously defined intervals 2 to S of Xq21 (Cremers et al. 
1990a) into subsegments, as depicted in Fig. 1. The rela­
tive order of all probes from these intervals could be es­
tablished. 
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The proximal breakpoint of the deletion in patient 
SD was mapped between intervals 1 and 2. Thus, with 
the available probes, the proximal boundary of this dele­
tion could not be distinguished from those of two previ­
ously studied patients, XL45 and DM. 
Locus DXS26 (probe pHU16) was found to be pre­
sent in the DNA of patient D20 but absent from DNAs 
of patients SD, DM and XL45. This implies that the 
DXS26 locus must be proximal to the genes involved in 
deafness and XLMR. -
The distal boundary of the region carrying the DFN3 
gene could be inferred from a study of a deletion found 
in the DNA of a patient with classical CHM. In this 
patient (LGL2905), who is neither deaf nor mentally 
impaired, the deletion includes the DXS121 locus (p784) 
but not the DXS232 locus (pJL68, see Fig. 1). There­
fore, the DFN3 and a putative XLMR gene locus must 
be located proximal to the DXS121 locus and distal to 
DXS26 (interval 2b). 
Discussion 
Isolated-X-linked deafness is a relatively rare and clini­
cally heterogeneous trait (Konigsmark and Gorlin 1976). 
Often, deafness is also part of a variety of other well-
defined disorders (e.g. albinism-deafness syndrome, or 
mucopolysaccharidosis type Π) that map to different 
regions on the X chromosome. 
Among the 4 types of nonsyndromic X-linked deaf­
ness distinguished by McKusick (1990), progressive 
mixed deafness with perilymphatic gusher during stapes 
surgery (DFN3) is the most frequent form, accounting 
for aboiá half of all X-linked deafness cases (Nance et al. 
1971). Phelps and coworkers (1991) have recently sug-
gested that the true proportion of DFN3 may be even 
higher because the sensorineural component in this type 
of deafness can progress very rapidly (Glasscock 1973), 
thereby masking the conductive component. 
Linkage analyses in large kindreds in which DFN3 is 
segregating have allowed the assignment of this disorder 
to the Xql3-q21 region (Brunner et al. 1988; Wallis et 
al. 1988). Further evidence for a deafness locus in this 
chromosomal region came with the identification, in 
male patients, of cytogenetically visible deletions that 
comprise at least part of Xq21, and that are associated 
with a complex phenotype including deafness, MR, CHM 
and other features (Nussbaum et al. 1987; Rosenberg et 
al. 1987; Schwartz et al. 1988; Wells et al. 1991; Reardon 
et al. 1992). 
Molecular analyses have enabled us and others to as-
sign the genes for deafness and XLMR to the same small 
interval of the Xq21 band (interval 2 in Cremers et al. 
1989b, 1990a; Merry et al. 1989). In this study, we have 
characterized two additional deletions that were found 
in patients suffering from deafness, MR and other fea-
tures. Furthermore, an overlap with a large deletion that 
has been found previously in a patient with classical 
CHM (Sankila et al. 1990) enabled os to exclude the 
deafness and XLMR genes from the distal segment of 
interval 2 and to map it between the DXS121 and 
DXS26 loci. 
Recent radiological studies in several unrelated fami-
lies with X-linked deafness have shed more light on the 
classification and differential diagnosis of this disorder. 
Employing high resolution computer tomography, char-
acteristic structural abnormalities of the inner ear could 
be demonstrated in patients with the mixed type of deaf-
ness and in others with pure sensorineural deafness. 
These abnormalities included bulbous internal auditory 
meatus (LAM), dilated facial canals, incomplete separa-
tion of the coils of the cochlea from the LAM, and wide 
first and second parts of the intratemporal nerve canal 
with a less acute angle between them. Since these char-
acteristic alterations give rise to an abnormal communi-
cation between the cerebrospinal and the perilymphatic 
fluid, it seems most likely that these structural changes 
are responsible for the gusher observed frequently at 
stapes surgery of patients with DFN3 (Phelps et al. 1991). 
Segregation studies, in families with these cochlear 
and temporal bone abnormalities, have consistently 
shown linkage with Xq21 markers. It is of note, how-
ever, that linkage with Xq21 loci was also found in a 
family that did not show these specific alterations. This 
indicates, that there is more than one deafness gene on 
the proximal long arm of the X-chromosome (Reardon 
et al. 1991), or alternatively, that allelic mutations cause 
different phenotypes. 
Of the patients described in this study, only probands 
XL62 and D20 exhibited mixed hearing loss, supporting 
the diagnosis of DFN3. Surgical treatment was per-
formed in patient XL62 only; this resulted in a peri-
lymphatic gusher when the stapedial footplate was 
opened (Merry et al. 1989). All other patients had pro-
found sensorineural hearing loss, indicating either the 
involvement of different genes, allelic variation or 
"masking" of the conductive defect by the profound sen-
sorineural hearing loss. The latter has been established 
for patient SD, who was shown to exhibit the same struc-
tural inner ear abnormalities as seen in DFN3 patients 
(Reardon et al. 1992). Similarly, patient XL4S has sen-
sorineural deafness, whereas mixed deafness was diag-
nosed in his younger brother (Ayazi 1981). This indi-
cates that the DFN3 gene is also involved in the hearing 
impairment in this family. To establish diagnosis in the 
other patients, radiological and audiological (reexami-
nation will be necessary. 
The observation that one of the previously studied 
patients (NP) does not show any signs of deafness, de-
spite his gross deletion spanning interval 1 to 6 of Xq21 
(Fig. 1) has hitherto been unexplained (Cremers et al. 
1989b). This finding indicates that the manifestation of 
deafness depends not only on the absence of the DFN3 
gene but also on other genetic or environmental factors. 
Alternatively, the chromosomal rearrangement of pa-
tient NP may be more complex than previously thought; 
however, since all markers from intervals 1 to 7 have 
been tested on the DNA of the patient (Fig. 1), there is 
no indication for this so far. Examples for such complex 
rearrangements have been previously described in a sex-
reversed patient (Page et al. 1990) and in a patient with 
adrenoleukodystrophy and colour blindness (Feil et al. 
1991). Isolation of new markers from the critical Xq21-
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region and long range restriction mapping will be useful 
for ruling out complex rearrangements ш our deletion 
panel and win enable us to complete the physical map of 
interval 2 of Xq21 (Cremers et al. 1989b; Merry et al. 
1989). Based on flow karyotype analysis, the deletion of 
patient XL45 has been estimated to comprise about 5.3 
Mbp (Merry et al. 1989). Long range restriction map­
ping around the TCD locus (i.e. the distal part of the 
XL45 deletion) gives a minimum size of 3.6Mbp for 
the DXS95-DXS232 region (W. Berger, unpublished 
results). Consequently, the chromosomal region be­
tween DXS232 and the proximal endpoint of the XL45 
deletion, which encompasses the DFN3 and XLMR loci, 
should not exceed 2-3 Mbp. 
It has been estimated that mutations in loci distinct 
from the fra(X) locus account for about 60% of all X-
linked mental retardation cases (Mikkelsen 1987). Link­
age studies in families with non fra(X)-XLMR and dele­
tion studies have defined at least one region on proximal 
Xq that may be involved in the etiology of this disorder 
(Arveiler et al. 1988; Sutherland et al. 1988; Cremers et 
al. 1989b, 1990a; Stevenson et al. 1991; Schwartz et al. 
1991). Moreover, several complex X-linked disorders in­
volving mental retardation have been assigned to this 
chromosomal region (Wieacker et al. 1985; Schwartz et 
al. 1990; Arena et al. 1991). These observations indicate 
that there is more than one gene in this region giving rise 
to mental retardation, or alternatively, that there is 
single gene defect that is relatively frequent 
Recently, a balanced t(X:13) (q21.1;q34) in a girl 
with profound mental retardation and minor additional 
symptoms, such as asymmetry of the face, clinodactyly 
of the index finger and a mild scoliosis, was described by 
Teboul et al. (1989). Assuming that the mental retarda­
tion in this girl is caused by a translocation within the 
XLMR locus, molecular studies m this patient should 
enable us to refine the localization of this locus and may 
significantly contribute to its isolation. 
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Summary 
Employing varions probes from the proximal part of die Xq21 region, which is known to harbor the DFN3 
gene, we have investigated 13 unrelated male probands with X-linked deafness, to detect possible deletions. 
For two of these patients, microdeletions could be detected by using probe pHU16 (DXS26). One of these 
deletions also encompasses locus DXS169, indicating that it extends farther toward the centromere. The 
presence of normal hybridization patterns in the DNA of 25 " H " ^ control males suggests that these 
deletions are the primary cause of progressive mixed deafness in these patients. If so, their molecular 
characterization may pave the way for the identification and isolation of the corresponding gene. 
Introduction 
X-linked progressive mixed deafness with perilym­
phatic gusher (DFN3; MIM 304400) which is recog­
nized during stapes surgery is a clinically well-defined 
disorder (Olson and Lehman 1968; Nance et al. 1971; 
Jensen et al. 1977; Cremers 1985;Cremers et al. 1985; 
Michel et al. 1991; Phelps «al . 1991) said to account 
for about half of all cases with X-linked hearing loss 
(Nance et al. 1971 ). Since the clinical picture of DFN3 
may be entirely dominated by sensorineural hearing 
loss (Glasscock 1973), it is likely that the incidence of 
this disorder is even higher (Phelps et al. 1991). 
Linkage studies in families with DFN3 have as­
signed the underlying gene defect to the Xql3-q21 
region (Brunner et al. 1988; Wallis et al. 1988; Rear-
don et al. 1991). This localization is supported by 
the phenotype of patients with cytogencacally visible 
deletions constituting part of the Xq21 band. In these 
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patients, gusher-type deafness, choroideremia (CHM) 
and nonspecific mental retardation (XLMR) are com­
mon clinical features (Tabor et al. 1983; Nussbaum 
et al. 1987; Rosenberg et al. 1987; Wells et al. 1991 ). 
Molecular characterization of these Xq21 delenons 
has enabled us and others to refine the assignment of 
the OFN3 gene to a small segment of Xq21.1 (Cremers 
et al. 1989, 1990л; Merry et al. 1989; Bach et al., 
m press) (fig. 1). By following essentially the same 
strategy which has enabled us to precisely map and 
subsequently clone the choroideremia gene (Cremers 
et al. 1987,1990b), we have now performed a system­
atic search for microdeletions in 13 unrelated male 
patients with X-hnked deafness, by employing mark­
ers from the relevant interval of Xq21.1. 
Patients and Methods 
Patients 
Clinica] data of the investigated probands are listed 
in table 1. The X-linked mode of inheritance for the 
patients was established on the basis of the following 
entena: (1 ) at least two affected males in the pedigree 
and (2) transmission of the deafness allele via female 
carriers. 
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Table I 
CHnfcaJ Dab far ПмГіні Pattai U» and Unkag· Date fer cha Commanding Famines 
Syndrome and Panent Radiological/Clinical Findings* Locos" LOD* б Other Features 
X-lmked (progressre) mixed Λ**(η***· 
TD Tmctacsofbonesofcalvarium, NI Hypogonadism, antisocial 
fixed stapes, gusher behavior 
FT Possible fixation of stapes, NI 
gusher 
1/10 Possmle fixation of sapes, DXY51 6.32 0 
gusher 
JvK Small cochkas with leans, FGK1 3.07 0 
trilateral dilatation of IAC, 
gusher 
5274 DOated facia] canals, structural DXYS1 3.03 0 
lésions of cochlea that cause 
тсошріек separation of 
penlymphanc and cere· 
brospmal fluid 
5482 Dilated facial canals, structural DX572 2.95 0 
lestons of cochlea that cause 
incomplete separanon of 
perilymphatic and cere­
brospinal fluid 
5106 Normal inner-car DXS95 3.01 0 
CT scan 
D20 NI N1 Retinal abnormalities 
seizures, MR 
Reference 
X-hnke<( sensorineural deafness: 
LS NI 
5086 DOated facial canals, structural 
lesions of cochlea that cause 
incomplete separanon of 
penlymphaac and cere­
brospinal fluid 
5736 Dilated baal canals, structural 
lésons of cochlea that cause 
incomplete separanon of 
penlymphanc and cere-
brospinal fluid 
5943 Normal inner-ear 
CT scan 
5347 Normal inner-ear 
CT scan 
X-lmked conductive deafness: 
DK N1 
N1 
DXYS1 1 15 
DXS72 1.03 
DXYS1 1 33 
DXS3 
N1 
1.20 
Short suture 
Myhre et al. 1982 
Thorpe et al. 1974 
Walks et al.1988 
Bninner et al. 1988; 
Cremers 1985; 
Cremers et al. 1985 
Phelps et al. 1991; 
Reardon et al. 1991 
Phelps et al. 1991; 
Reardon et al. 1991 
Phelps et al. 1991; 
Reardon ее aL 1991 
Wells et al. 1991; 
D. G. Rooms, 
personal соишшш-
canon 
H. G. Brunner, 
unpublished dan 
Phelps et al 1991. 
Reardon et al. 1991 
Phelps et al. 1991; 
Reardon et al. 1991 
Phelps et al. 1991; 
Reardon et al. 1991 
Phelps et al. 1991; 
Reardon et al. 1991 
H G Brunner, 
unpublished data 
'NI a not 
Method! 
Southern anehss.—Methods employed for the isola­
tion of high-molecular-weight DNA, restriœoD-endo-
nudease digestion, as well as separation, blotting, and 
hybridization of DNA fragments, have been described 
elsewhere (Bach et al., in press). 
Bfood tampini end freezing.—Blood from patients 
DK, TD, PT, JvK, and D20 was drawn in a vacutainer 
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tube with die anticoagulant lithium heparin. Blood 
samples from the other patients were not available. 
Blood samples (2.5 ml) were mixed with 2 ml FCS 
(Flow Laboratories) and 0.5 ml dimethylsulfoxide 
(DMSO) and slowly were frozen down, in three ali-
quots at - 70°C. Thereafter the blood was stored in 
liquid nitrogen until use. 
Epstein-Bar vine (EBV) tram/in mutimi.—Blood was 
thawed rapidly in a 37°C water bath and slowly was 
diluted in б ml RPMI1640 (supplemented with 10% 
FCS and 50 ug gcntamycin/ml. Cells were centrifuged 
for 5 min at 180 g and were washed once in 2 ml RPMI 
1640, and the lymphocytes were counted. The white 
blood cell pellet was resuspended in 0.5 ml EBV-
saturated supernatant from B95-8 cells, and incubated 
for 2.5 h in a 37°C 7.5% СО
г
 incubator. This super­
natant was made by growing the B95-8 cells in RPMI 
1640 for 4 d, with a starting cell concentration of 
1 χ 10V ml. After incubation, the lymphocytes were 
spun down, resuspended at a concentration of 2-3 ж 
10*/ml RPMI 1640, and plated in a 96-well polysty­
rene tissue culture plate (100 ul cell suspension/ well). 
After 24 h, 50 ul cyclosporin (0.6 ug/ml RPMI 
1640) /well were added, a procedure which, after 7 d, 
was repeated with 50 ul cydosporine (0.8 pg/ml 
RPMI 1640). After 14 d, the medium was refreshed 
twice a week, until dumps of growing cells arose. Cells 
have been cultured at a density of 4-5 χ IO5/ml and 
have been frozen in >7 χ 10* cells/vial in 1.5 ml 
RPMI 1640 + 10% DMSO. 
Puked-Field Get Electrophoresis (PFGE) 
Lymphoblastoid cells from patients D20 (Wells et 
al. 1991), DK, TD, PT, and JvK were embedded in 
low-gelling-temperature agarose (Biorad), at a final 
concentration of 3 χ IO7 cells/ml. Plugs were equili­
brated in 0.5 M EDTA, 1% lauroylsarcosine, and 
were treated with proteinase К (final concentration 
0.5 mg/ml; Boehringer) for 12 h at 50°C. Then the 
plugs were rinsed with Aqua bidest (4 χ 10 min) and 
subsequently were treated with 10 mM Tris, 0.5 mM 
EDTA, 0.1 mM phenylmethyl-sulfanylfluorid (PMSF-, 
Boehringer) and 10 mM Tris, 0.5 mM EDTA ( 2 x 2 
h). After extensive preequilibration in 1 χ restriction 
buffer, plugs were digested with 20 U 5/51 (Biolabs) for 
2 h at 50°C. 
Restriction fragments were separated in a 1% aga­
rose gd (Seakem Gold; FMC) with a contour-damped 
homogeneous electric field (CHEF) apparatus under 
the following conditions: 0.25 x TBE, continuous 
buffer flow, 150 V, switch time 120 s, at 4°C for 48 
h. Afterward, the gd was rinsed 2 χ 15 min in 0.15 
M HO and 2 χ 30minin0.5MNaOH,1.5MNaCl 
and subsequently was blotted onto a GeneScreen Plus 
membrane (NEN) by using a standard Southern trans­
fer (Sambrook et al. 1989). (Pre)hybridization and 
washing procedures have been described dsewhere 
(Sambrook et al. 1989). 
ONA Probes 
Probe pHU16 (DXS26) has been described in detail 
by Sankila et al. (1990). AU other probes have been 
described elsewhere (Nussbaum et al. 1987; Davies et 
al. 1991). For probes pHU16 (DXS26) and pX104f 
(DXS169), preannealing with sheared human DNA is 
required. 
Results 
With probes located within (pJL68) or flanking 
(pX65H7, pX104f, pHU16, and p784) the region 
which is thought to harbor the DFN3 gene, 13 unre­
lated patients with various forms of X-lmked deafness 
have been investigated for chromosomal rearrange­
ments. For two probands (1/10 and TD) with DFN3, 
microddetions could be identified, whereas all other 
patients show no gross alterations. In patient TD the 
deletion was only detectable with the pHU16 probe 
(locus DXS26; fig. 2). The DXS26 locus was also 
shown to be deleted in patient 1/10, but here the dele­
tion encompasses the DXS169 locus as well, which 
means that it extends farther in the centromeric direc­
tion (fig. 1). 
Normal hybridization patterns were observed for 
the flanking lod DXS121 (p784), DXS232 (pJL68), 
and DXS72 (pX65H7) (data not shown). To rule out 
the possibility that probe pHU16 detects a ddetion 
polymorphism, DNA of 25 male controls was hybrid­
ized with this probe. The normal hybridization pat­
tern was observed consistently (data not shown). 
Recently we have studied another cytogenetically 
visible interstitial ddetion of the Xq21 band (D20; 
Wells et al. 1991) in a male with mixed deafness, 
XLMR, and other symptoms (Bach et al., in press). 
In the DNA of this patient, locus DXS232 was found 
to be deleted, whereas locus DXS26 was present. This 
suggests that the DFN3 gene maps between these two 
markers, i.e., proximal to DXS232 and distal to the 
DXS26 focus which is ddeted in patients TD and 
1/10 (fig. 1). 
In an attempt to bridge the distance between these 
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figure t • 
окегг рхавнг 
D I S » · pXtiMI 
C K · » jjHUW 
OXUSC PJLB8 
QKBiai P78« 
oxsm PJL« 
ХдЗІ.1 
¡rati 020 TD Ю 2906 
Figure I Fine mapping of a putative deafness-gene locus to 
a specific deletion interval of Xq21.1, by employing conventional 
Southern analyses and PFGE studies. Deletions are indicated by the 
hatched columns. The region of overlap which should harbor the 
DFN3 gene is shown as a shaded box. The Sfil fragments detected 
by probes pHUli and pJL68 and Banking the DFN3 region are 
indicated by vertical lines. A putative XLMR locus has been as· 
signed slightly more distal to the DFN3 gene, which is depicted 
by the unshaded box. The deletion intervals of this chromosomal 
segment are defined by numerous deletion breakpoinrs (Cremers et 
al. 1989) and are numbered consecutively. HG » hypogonadism. 
two loci and to define the proximal and distal bound­
aries of the deletions D20 and TD, respectively, long-
range restriction mapping was performed. Probe 
pHU16 (DXS26) failed to detect aberrant bands in 
S/ÏI-digested DNA of patient D20, and the same was 
true for probe pJL68 (DXS232) and patient TD (data 
not shown). Hybridization patterns were also normal 
in three other probands (DK, PT, and JvK); that is, no 
other microdeletions could be detected. 
Discussion 
Deafness with or without stapes fixation, CHM, 
and/or XLMR are the most prominent—and often 
only—clinical features of Xq21 deletions (Cremers et 
al. 1990a), which suggests that, genetically, the Xq21 
band is relatively inert. This may explain why nulli-
somy for the entire Xq21 band is compatible with 
life, whereas, for most other regions of the X, large 
male-viable deletions are never observed (Ropers 
1987). Indeed, systematic screening with DNA probes 
from the Xq21 band has enabled us to detect several 
large and numerous small deletions in patients with 
classical, nonsyndromic CHM (Cremers et al. 1990ο); 
J? 
./> АЛ^ Л ^ «>W ff* я/ 
pX104f 
(DXS169) 
pHU16 
(DXS26) 
pJL68 
(DXS232) ÊÊÈmmumtËÈmmmmÊÈ 
Figur« 2 Deleam detection mrwopaáraa with DTO3, оу enmlcTi i igp^ 
tested on EcoRI- and/or Тд^І-digested genomic DNA of 4 controls (5X cell line/female/male/46, XY, del (X) (q21)—and on 13 unrelated 
males with X-linked nrafnm. Relevant sections of the autoradiograms were selected and arranged according to the chromosomal location 
(see fig. 1). Hybridization signals of probe pJL68 (DXS232) are shown in the lower row. 
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and these deletions were the due to the subsequent 
isolation of die CHM gene (Cremers et al. 1990b). 
In the course of these studies, we have also mapped 
the genes underlying XLMR and DFN3, to small inter­
vals of the Xq21 band (Cremers et al. 1989; Bach et 
al., in press). Now we have employed DNA probes 
from this interval, for microddetion screening in 13 
unrelated patients with X-linked deafness. Two dele­
tions were found with the same probe, рНШб, 
(DXS26); one of these was in a patient (1/10) with 
nonsyndromic, classical DFN3 who was a member of 
the large Mauritian kindred that has been described 
elsewhere (Wallis et al. 1988). In the other patient 
(TD) DFN3 was associated with familial hypogo­
nadism (Myhre et al. 1982). In patient 1 /10, the dele­
tion spanned also the DXS169 locus, the closest flank­
ing proximal marker. Since PFGE experiments were 
not practicable for patient 1/10 and were not further 
informative for patient TD, no physical refinement 
of the deletion breakpoints in both patients could be 
obtained (fig. 1). Our findings suggest that the DFN3 
gene maps in the dose vicinity of the DXS26 locus. 
Therefore, it is surprising that this marker is not con­
tained in the large deletion, D20, which Wells et al. 
(1991) observed in a boy with mixed deafness and 
XLMR (Bach et al., in press). Because the dosest dis-
tally flanking locus, DXS232, is deleted in this patient, 
these observations may indicate that the DFN3 gene 
is located between DXS26 and DXS232. At least for­
mally, it is also possible, however, that the D20 dele­
tion spans another deafness locus which is slightly 
more distal in band Xq21. Inner-ear polytomography 
in patients with DFN3 has previously demonstrated 
abnormal dilatation of the internal acoustic canal 
(LAC), as well as an insufficient structural separation 
between LAC and the basal coil of the cochlea (Jensen 
et al. 1977; Cremers 1985; Cremers et al. 1985). Clini­
cal studies involving computer tomography (CT) of 
the temporal bones and of the inner ear recently have 
further delineated these typical osseous defects which 
seem to be pathognomonic for DFN3 (Michel et al. 
1991; Phelps et al. 1991; Reardon et al. 1991, and in 
press-α, in press-ύ). Absence of these features in other 
families with X-linked deafness, as well as the finding 
that, in most (but not all) families, the hearing impair­
ment is linked to Xq21 markers has provided dear 
evidence for clinical and genetic heterogeneity of this 
disorder. Against this background, further support for 
the localization of the DFN3 gene between DXS26 
and DXS232 may be expected from a clinical reexami­
nation of patient D20. 
Clinical examination involving audiology and CT, 
as well as linkage analyses, has been performed in 
several of the 13 patients and their families that were 
the subject of our present study. For six of these (TD, 
PT, JvK, 1/10, 5274, and 5482), induding the two 
patients (1/10 and TD) with microdeletions, the diag­
nosis of DFN3 could be established clinically and 
audiologically (see table 1). In two other patients 
(5086 and 5274) with sensorineural deafness, co­
chlear lesions were found which were characteristic 
for DFN3. Therefore it is likely that, in at least 8 of 
these 13 patients, the hearing impairment is due to a 
defect of the DFN3 gene. This is in keeping with the 
notion that the DFN3 gene is the most important cause 
of X-linked deafness. Microdeletions were found in 
two of these eight patients with proved DFN3 but in 
only one (i.e., patient 1 /10) of these was deafness the 
sole dinical feature. Thus, one of seven patients with 
dassical, nonsyndromic DFN3 had a deletion of the 
DXS26 locus. This observation coincides with the fre­
quency of deletions in patients with CHM (Cremers et 
al. 1989; F. P. M. Cremers, unpublished observa­
tions) and opens up exciting prospects for the isolation 
of the DFN3 gene. 
In the case of CHM, evolutionarily conserved se­
quences from a small genomic segment of overlap be­
tween several microddetions were the due to the isola­
tion of a candidate gene, and mutation analysis has 
recently provided unambiguous proof for this gene's 
causal role in this eye disorder (van den Hurk et al., 
in press). Similarly, characterization of microdeletions 
spanning the DFN3 locus should be the due to the 
duddarion of its structure. 
The observation that one of the microdeletions is 
associated with both DFN3 and hypogonadism sup­
ports our previous hypothesis (Brunner et al. 1991) 
that this phenotype (MIM 30435) represents a 
contiguous-gene syndrome. If so, this finding assigns 
the gene underlying hypogonadism to a small Xq21 
segment in the vicinity of the DXS26 locus. 
Finally, these observations have refined the localiza­
tion, within band Xq21, of a gene underlying XLMR. 
Previous characterization of cytogenetically detect­
able large deletions of the Xq21 band had mapped this 
gene to the same interval as that containing the DFN3 
gene (Cremers et al. 1990α, Bach et al., in press). 
Because both patients with DFN3 and microddetions 
spanning DXS26 are mentally normal, these findings 
exdude the XLMR gene from the deleted segment and 
support a slightly more distal map position (fig. 1). 
It is possible, however, that the absence of disease 
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genes in this region may not always give rise to the 
expected clinical phenotype. Indeed, one of our pa­
tients who has been studied by others and who has a 
large deletion spanning the DFN3 interval (Tabor et 
al. 1983; Cremers et al. 1989) is definitely not deaf 
(M. Schwartz, personal communication). Similarly, 
another patient with a large Xq21 deletion spanning 
the CHM locus (patient RvD; see Cremers et al. 1989) 
did not show any sign of CHM at the age of 13 years, 
which is difficult to reconcile with the absence of this 
gene. The presence of hypogonadism in patient TD 
and in all of his deaf male relatives (Myhre et al. 
1982)—but its absence in patient 1 /10—may be due 
to the same phenomenon. Since the deletion in 1/10 
includes not only DXS26 but also the DXS169 locus, 
it must extend beyond the proximal end of the region 
of the deletion in TD. If it is assumed that the microde-
letion in patient 1/10 and the large D20 deletion over­
lap—that is, if the deafness in both patients is due to 
the absence of the DFN3 gene—then there may be no 
room on the distal side for a gene that is necessary to 
prevent hypogonadism in males. However, to the best 
of our knowledge, neither patient D20 nor any of the 
other patients with large Xq21 deletions have been 
formally assessed for presence or absence of hypergo-
nadotrophic hypogonadism. It is not certain, how­
ever, that these deletions are simple and contiguous. 
Indeed, more-complex rearrangements have been ob­
served, both in a sex-reversed patient with a deletion 
of the Y chromosome and in a patient with adrenoleu-
kodystrophy, colorblindness, and a deletion involving 
part of the Xq28-band (Page et al. 1990; Feil et al. 
1991 ). At present there is no convincing explanation 
for the apparent inconsistencies in our patients. This 
may indicate that the absence of specific symptoms in 
patients with deletions is a less reliable criterion for 
the mapping of disease genes. In our ongoing studies 
aiming at the isolation of the genes underlying DFN3, 
XLMR, and hypogonadism, this will have to be con­
sidered. 
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We have found that the microsatellite marker 
AFM207zg5 (DXS995) maps to all previously described 
deletions which are associated with X-llnked mixed 
deafness (DFN3) with or without choroideremla and 
mental retardation. Employing this marker and pHU16 
(DXS26) we have Identified two partially overlapping 
yeast artificial chromosome clones which were used 
to construct a complete 850 kb cosmid corrog. Cosmids 
from this contig have been tested by Southern blot 
analysis on DNA from 16 unrelated males with X-llnked 
deafness. Two novel microdeletions were detected In 
patients which exhibit the characteristic DFN3 
phenotype. Both deletions are completely contained 
within one of the known DFN3-deletions, but one of 
them does not overlap with two previously described 
deletions in patients with contiguous gene syndromes 
consisting of 0FN3, choroideremia, and mental 
retardation. Assuming that only a single gene is 
involved, this suggests that the DFN3 gene spans a 
chromosomal region of at least 400 kb. 
INTRODUCTION 
X-linked mixed deafness with perilymphatic gusher at surgery 
in males (DFN3; MJM 304400) is characterized by a severe 
hearing loss involving all frequencies, that may be progressive. 
About 50% of female heterozygotes show mild to moderate 
hearing impairment. Audiological studies indicate a basic 
sensorineural hearing loss, with the variable conductive element 
postulated to reflect outward perilymphatic pressure splinting the 
stapes footplate in the oval window (1). On opening of the stapes 
footplate during surgery, an abnormal amount of perilymph is 
encountered. Computerized tomography (CT) studies have 
demonstrated an abnormal dilatation of the internal acoustic canal 
(IAQ as well as an insufficient structural separation between the 
TAC and the basal coil of the cochlea (2-4). 
Linkage studies in families with X-linked deafness have 
assigned the underlying gene to the Xql3-q21 region (4-7). 
This localization is supported by the phenotype of patients with 
cytogenerjcally visible deletions of Xq21 region, which includes 
choroideremia (CHM), mental retardation (MR) and DFN3 
(8-12). Moleoilar characterization of Xq21 deletions has enabled 
us and others to refine the assignment of the DFN3 gene to a 
small segment of Xq21.1 (13- IS). Subsequent examination of 
patients with classic DFN3 revealed the existence of two 
submicroscopic deletions encompassing DXS26 (cases TD and 
1/10; Figure 1) (16). 
We now have employed yeast artificial chromosome (YAC) 
and cosmid contig cloning to characterize a 830 kb chromosomal 
segment encompassing DXS26 and DXS995. This has enabled 
us to fine map several classic and syndromic DFN3 deletions 
and to identify two novel microdeletions. Some of the deletions 
are non-overlapping, which suggests that we have cloned a 
sizeable part of the DFN3 gene in cosmid clones. 
RESULTS 
Identification of YACs from the DFN3 region and 
construction of a cosmid contig 
Physical mapping of several recently isolated X-chromosomal 
markers using a deletion panel described by Philippe et al. (17) 
revealed that the microsatellite marker AFM207zg5 (DXS995) 
does not only map to large deletions of the Xq21 band which 
are associated with X-linked deafness, CHM, and MR, but also 
to two previously described microdeletions (TD and 1/10) in 
patients with non-syndromic DFN3 (Philippe et al. in 
preparation). 
By screening a human YAC library (18) with the probes 
AFM207zg5 and рНШб, we were able to isolate two YAC 
clones, nos 5045 and 4893, respectively. Physical mapping of 
YAC endclones generated by the ligation-mediated polymerase 
chain reaction (LM-PCR) procedure (19), indicated that YAC 
5045 is chimaeric containing an autosomal fragment at its 
proximal side (Figure 1). High molecular weight DNA from both 
YACs was used to construct cosmid libraries consisting of 
approximately 2500 independent clones for each YAC clone. 
Cosmids containing human inserts were identified and gridded 
on to several nylon membranes. Cosmid contigs were established 
by colony hybridization or Southern blot analysis of EcoRl-
digested cosmid DNAs with pHU16, YAC endclones, and 
iterative hybridization of cosmid inserts. Two EcoRI restriction 
maps were constructed spanning a total of approximately 800 
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kb. YAC 4893 was completely represented m the coring, whereas 
both the distal end of YAC 5043 as well as the chromosomal 
region spanning DXS995 were found to be absent. 
To close the gap m the vicinity of DXS995, cosnuds 5045F4 
and 5045B12 were used to perform cosmid walking employing 
the ICRF Cosmid Reference Library (20) Three rounds of 
cosmid walking resulted in the identification of three new cosnuds 
(ICI—IC3), which close the cosmid gap (Figure 1) 
Fine mapping of deletions associated with compta syndromes 
and identification of novel mkrodeletions in DFN3 patients 
Aforl/BrcHII-inserts of me cosmid clones indicated in Figure 1 
were hybridized to EcoKI or Taql digested DNAs from 
syndromic and classic DFN3 patients as well as to EcoRI digested 
DNA from a patient showing choroideremia and mental 
retardation. The latter patient, AP, has a deletion which 
encompasses exons 2 through 15 of the CHM gene as well as 
the more proximally located DNA markers DXS165, DXS233, 
DXS 121, and DXS232 (van der Maarel et al. in preparation) 
The proximal deletion endpoint is situated ш cosmid 5045B11, 
approximately 30 kb from the distal end of the cosmid contig 
Detailed analysis of the deletions found in the 'syndromic' DFN3 
patients D20 and XL45 positioned their respective breakpoints 
just proximal to DXS995 and DXS26, respectively (Figure 1) 
The proximal deletion breakpoints in other patients with 
syndromic *"•<"*«= (DM and SD) mapped proximal to the cosmid 
contig and therefore do not provide additional mapping 
information. 
Southern blot analysis of DNA from 16 unrelated patients with 
non-syndromic X-linked deafness using all cosnuds from the 
contig resulted in the identification of two novel microdeletions, 
II-7 and G8314, as shown in Figure 2 This figure is a typical 
example of using NotVBssHU cosmid inserts in a competitive 
DNA hybridization assay The deletion in panent 1/10 
encompasses the DNA loci DXS995, DXS26, and DXS 169 The 
deletions in patients П-7 and G8314 merely span DXS26 and thus 
are entirely contained within the microdeleoon seen m patient 
1/10 (Figure 1) Interestingly, the G8314 deletion does not 
overlap the deletions of patients D20 and XL45 The distance 
between the proximal deletion endpoint m D20 and the distal 
deletion endpoint in G8314 is approximately 400 kb 
DISCUSSION 
We have established a cosmid contig spanning the critical region 
for DFN3 and have identified two novel, highly lnformanve 
deletions associated with X-linked deafness Taken together, we 
have now found four microdeletions (TD, 1/10, П/7, and G8314) 
among 16 patients with X-linked deafness In all four patients 
with microdeletions the bony changes indicative of DFN3 were 
observed For two patients suffering from X-linked deafness, 
choroideremia and mental retardation, D20 and XL45, the 
deletions were shown not to overlap with the deletion m patient 
G8314 In panent D20, the structural changes of the inner ear 
indicative of DFN3 has been demonstrated by CT (21) Although 
patient XL45 was reported to have sensorineural deafness (22), 
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Figure 2. Santera btot analysis ЫЕаМ digested genomic DNAs from paòena 
with X-linked deafness employing cosmid 4893E1. Size marken are given to 
the right. X-only represents ceO line 578, a hamster cell line comaining one human 
X chromosome. 
it is possible that the DFN3 gene is involved in this case too. 
Glasscock (23) hypothesized that a very rapid progression of the 
sensorineural component of DFN3 can mask the conductive 
element. Since in a younger brother of XL45 mixed deafness 
was diagnosed (13), it is tempting to speculate that deafness in 
both brothers is caused by a (partial) deletion of the DFN3 gene. 
Linkage studies suggest that X-linked sensorineural deafness is 
genetically heterogeneous (7), but this has not been demonstrated 
for the mixed type of X-linked deafness. Assuming that only one 
gene is involved in DFN3, our results indicate that the DFN3 
gene spans a chromosomal segment of at least 400 kb containing 
both the DXS995 and DXS26 loci. However, it is possible that 
there are additional rearrangements in the X-chromosome of some 
of the patients with deletions. Within the limits of resolution of 
conventional Southern blotting, this has been excluded in the 
cosmid contig region for patients TD, G8314 and П/7, but not 
for patients 1/10, D20, and XL45. If the rearrangements in the 
DFN3 patients presented here are not complex, the DFN3 gene 
might well be the second largest gene known to date, after the 
Duchenne muscular dystrophy (DMD) gene which spans 
approximately 2.3 Mb (24-26). The DMD and DFN3 genes 
are located in Xp21 and Xq21, respectively, the most prominent 
Giemsa dark-staining regions of the X-chromosome. Another 
gene from Xq21, the choroideremia gene, also spans a sizeable 
( > 150 kb) chromosomal segment (27). Only two of IS deletions 
associated with classic CHM are intragenic; the others extend 
both proximal and distal of the gene spanning a chromosomal 
segment of approximately IS Mb (14,27). The classic DFN3 
deletions described here encompass chromosomal segments of 
a minimum of 250 kb (patient G8314) to several megabases 
(patient 1/10). Together, these fmdings support the idea that the 
Xq21 band contains a relatively small number of large genes. 
If so, this has important implications for cloning strategies aiming 
at the identification of sequences of the DFN3 gene proper. 
We did not find smaller-sized deletions among our X-linked 
deafness patients, which might narrow down the search for some 
of the protein coding sequences of the DFN3 gene. In the cosmid 
contig presented here, no CpG island indicative of the presence 
of the 5 ' end of the DFN3 gene was found. It is, however, 
possible that a sizeable portion of the gene is located proximal 
to YAC 4893. To investigate this chromosomal segment, we have 
identified a YAC clone spanning DXS26 and DXS169, which 
is currently under investigation. 
Assuming the existence of widely spaced small exons, as for 
example in the DMD and CHM genes, it might be difficult to 
find exons of the DFN3 gene by analysing cosmid clones for 
evolutionary conserved sequences. Alternative methods as for 
example exon trapping and cDNA enrichment protocols are 
underway, which should scon enable us to identify DFN3 protein 
coding sequences. 
MATERIAL AND METHODS 
PaHents 
AH patients except AP, U/7, and G8314 have been extensively described elsewhere 
(15,16; and references therein). Patient AP suffers (rom CHM and MR (van der 
Maarel aal., in preparation). Patients U/7 and G8314 show the classical features 
of DFN3 including the typical CT scan changes of me inner ear (4; M.Bitner-
Glindzicz, unpublished data). 
YAC done screening and construction of YAC cosmid cnntJgs 
YAC 4893 (lCRFy901E1023) was isolated by hybridization with pHU16 from 
primary library filters of the human ICRF human YAC library (18). YAC 5045 
(ICRFy9O0B1210) was identified by a PCR screening protocol from pooled DNAs 
from the same library. Yeast cell cuhuring and DNA isolation was performed 
as described elsewhere (28). YAC endclones were generated by the ligation 
mediated polymerase chain reaction (LM-PCR) protocol essentially as described 
by Kere «raí. (19). Restriction enzyme digestion of yeast DNA pnor to ligation 
of adaptors was done with Alul, EcoKV. Rsal, or Pvuü The procedure used 
for constructing cosmid libraries in the SuperCos I vector (Stratngene) has been 
described elsewhere (29). 
Cosmid walking 
DNA was isolated from cosmids S045F4 and S045B12 using a Qiagen midi-prep 
IriT and Higgflrri iismg wrtwr F/wPI nr Pqt armwting In mannfarfiinr'c і т т т і і п п с 
Fragments were Southern blotted and hybridized with radirilabeUed liunam placental 
DNA (Sigma), washed in 0.1XSSC. 0.1 % (w/v) SDS for 30 min at 65'C and 
«posed to X-ray film for 3-24 h at -70°C. A band showing no signal was 
selected as a probe for the next part of the walk, excised from a 0.8% agarose 
gel and spun through glass wool at 13 000 r.p.m. for 10 min. Probes were 
preannealed with human competitor DNA. 
ICRF gridded X chromosome cosmid filters were hybridized as described by 
Nizetic a aL (30) and positive colonies selected. Digests of DNA from positive 
colonies were compared with those of flanking cosmids, blotted and probed with 
the band which had originally been used to selea them from the gridded niter, 
to ensure that they were true positive colonies. The whole process of probing 
with human placental DNA and band selection was repeated at the next stage 
of the walk. Three such rounds of hybridization and walking were needed to 
bridge the gap in the cosmid contig around DXS995 and resulted in the 
identification of the following clones: ICI (ICRFcl04P0517), IC2 
(ICRFcl04L0131). IC3 (ICRFC104B1939). 
Southern blot analyse and DNA markers 
Methods employed for the isolation of high-molecular-weignt DNA, testnetion-
endonudease digestion, as wefl as scpaiaüun and btomng of DNA fragments have 
been described elsewhere (15). Hybridization of the cosmid inserts in the presence 
of excess human competitor DNA was done as described by Blonden et al. (31). 
Hybridized filters were washed at 65°C with 40 mM Na,HP04 (pH 7.2)/0.5% 
(w/v) SDS tor 3x5rmn and 1x30 min. Autoradiography took 4 -16 h at - 7 0 4 : 
using two intensifying screens. 
The markers pJL68 (DXS232). ргШІб (DXS26). pX104f (DXS169), and 
AFM207zg5 (DXS995) have been described elsewhere (932-34). 
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Association Between X-Linked Mixed Deafness 
and Mutations in the POU Domain Gene POU3F4 
Yvette J. M. de Kok,* Silvera M. van der Maarel,* 
Maria Bitner-Glindzicz, Irene Huber, Anthony P. Monaco, 
Susan Malcolm, Marcus E. Pembrey, Hans-Hilger Ropers, 
Frans P. M. Cremerst 
Deafness with fixation of the stapes (DFN3) is the most frequent X-linked form of hearing 
impairment The underlying gene has been localized to a 500-kilobase segment of the 
Xq21 band Here, it is reported that a candidate gene for this disorder, Brain 4 (POU3F4), 
which encodes a transcnptaon factor with a POU domain, maps to the same interval In 
five unrelated patients with DFN3 but not in 50 normal controls, small mutations were 
found that result m truncation of the predicted protein or in nonconservative amino acid 
substitutions. These findings Indicate that POU3F4 mutations are a molecular cause of 
DFN3 
Severe, inherited childhood deafness oc­
curs in about 1 out of 1000 births and 
presents a senous worldwide public health 
problem (1) In 70% of these cases, deafness 
is not associated with other clinically rec­
ognizable features (2) To date, genes for 
nonsyndromic sensorineural deafness have 
been mapped to five different autosomes 
(3), but none of these has been isolated yet 
The most frequent cause of X-linked hear­
ing impairment, X linked mixed deafness 
(DFN3) (McKusick catalog number 
304400), is characterized by a conductive 
hearing loss that results from stapes fixation 
and progressive sensonneural deafness (4, 
5) However, a profound sensorineural deaf-
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ness sometimes masks the conductive ele­
ment (6) Computenzed tomography (CT) 
studies in people with DFN3 demonstrated 
an abnormal dilatation of the internal 
acoustic canal (1ЛС) as well as an abnor­
mally wide communication between the 
S о « 
δΐΛ-aMfc*» ΑίΑβΣ 
pKlMf 
ЛР-І-//-
D20-1-//-
XL4SJ-//-
1AC and the inner ear compartment (7) As 
a result, there is an increased perilymphatic 
pressure that is thought to underlie the 
observed "gusher" dunng the opening of 
the stapes footplate The gene underlying 
DFN3 has been mapped to Xq21 by linkage 
analysis (8 9) and through molecular char­
acterization of large and submicroscopic de­
letions (10, 11) Yeast artificial chromo­
some (YAC) clones that span the critical 
region were isolated, and an 850-kb cosmid 
contig was constructed (12) This enabled 
us to identify and characterize two addition­
al microdeletions, as well as a 150-kb dupli­
cation in patients with DFN3, and to assign 
the gene underlying DFN3 to a 500-kb 
interval of Xq21 1 (12, 13) (Fig IB) 
Recently, the gene Bram 4 (Pou3/4), 
which codes for a transcription factor, was 
mapped between the proteohpid protein lo­
cus Pip and the DXMito marker near the 
phosphoglycerate kinase I (Pgfcl) gene on 
the murine X chromosome (14) The chro­
mosomal region between Pgkl and Pip is 
evolutionanly conserved between humans 
and mice, which suggests that the human 
POU3F4 gene is located in the Xql3-q22 
»Him 
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Fig. 1 Localization of the human POU3F4 gene (A) Southern blot analysis with the use of a mouse 
Pou3f4 probe and a control probe o-ammolevulinate synthetase (AMS2) with genomic DNAs from a 
control male D20 and TD (76) Patient D20 has choroideremia (CHM) mental retardation (MR) and 
X linked mixed deafness (DFN3) pabent TD shows evidence of DFN3 (12) (B) Physical map of the DFN3 
critical region All patents with deletions have been descnbed elsewhere (72) Patent 5086 cames e 
150 kb duplication spanning DXS26 The extent of the cosmid contig is given at the bottom POU3F4 is 
located on cosmids IC2 (ICRFc104L0131) and ЮЗ (ICRFOI04B1939) approximately 20 kb distal to 
DXS995 (72) Restnctjon mapping of the cosmid containing the FOU3F4 gene indicated that the POU3F4 
gene is oriented with its 5 end toward the centromere 
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interval The rat homolog of POU3F4, 
RHS2, is expressed during embryonic devel­
opment in the brain, the neural tube, and 
the otic vesicle at 15 5 and 17 5 days after 
conception (15). 
Thus, both its map position and its tem­
poral and spatial expression pattern in early 
embryogenesu rendered POU3F4 an attrac­
tive candidate gene for DFN3 To confirm 
and refine the localization of the human 
POV3F4 gene, we amplified a murine 
genomic Pou3f4 gene fragment by poly­
merase chain reaction (PCR) and hybrid­
ized it to Southern (ΟΝΛ) blots containing 
Eco RI-digested DNA from patients with 
Xq21 deletions (16) A 12-lcb Eco RI frag­
ment was seen in the male control but not 
in the DFN3 patients TD and DZO who 
carry vanably sized deletions in Xq21 (Fig 
1 A) The deletions overlap in a small chro­
mosomal segment encompassing DXS995 
(Fig IB), which positions the POUÌF4 
gene in a 120-lcb region of the previously 
constructed 850-kb cosmid contig that 
spans the DFN3 locus. By hybridizing the 
Pou3f4 probe to cosmids from this contig, 
we could localize the POU3F4 gene 20 kb 
distal to DXS995 (Fig IB). 
We used PCR pnmers complementary 
to the murine Pouift gene sequences to 
amplify a human POU3F4 fragment from 
cosmid DNA, which was then used as a 
probe to screen a human fetal bram com-
plementary DNA (cDNA) library (17) 
Six overlapping cDNAs were identified 
and partially characterized In total, we 
isolated 1 4 kb of the human POU3F4 
cDNA sequence, which contained the 
complete protein coding region of 1083 
base pairs as inferred from the rat RHS2 
and mouse Pou3{4 sequences (15, 18, 19) 
(Fig 2) The rat and mouse proteins are 
completely identical, and the human pro-
tein contains only four conservative ami-
no acid substitutions (Fig 2) 
To search for mutations in the POU3F4 
gene, we examined DNA from 14 unrelated 
patients with X-linked deafness and 50 un-
related control females from different eth-
nic ongrns for single-strand conformation 
(SSC) variants (20) Because the POU3F4 
gene contains no mtrons, five different 
PCR pnmer sets were sufficient to span the 
ennre codmg region of POU3F4 Six of the 
deafness patients (Table 1 ) had character-
istic features of DFN3—that is, a bony de-
fect observed during CT scanning or a pen-
lymphatic gusher encountered upon stape-
dectomy (4-7) In one case (patient 5823), 
audiologic data were consistent with a pro-
gressive mixed type of deafness, but neither 
CT scan nor stapes surgery were performed 
SSC stufa indicative of sequence alter-
ations were found m four DFN3 patients, 
two of which are shown in Fig. ЗА, but not 
in the 50 control females 
Subsequently, we sequenced the protein 
coding region of the POU3F4 gene in all 
patients with X-linked hearing impairment 
In all four patients with SSC shifts as well as 
in panent 5823, who was not studied by 
PCR-SSC analysis, mutations were observed 
in the POU3F4 gene In three DFN3 pa­
tients, we found small deletions in the 
POU-spectfic and POU homeodomains of 
POU3F4 that would result m fcameshifts and 
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Hg. Ζ Nucteotide sequence and the deduced ammo actd sequence encoded by human POU3F4 (27] 
The obgonudeottdes used for PCR-SSC analysis are indicated with arrows The POU-epecrfic and POU 
homeodomaflTS are boxed The human POU3F4 protein is (denteai to the protetn in mce and rats except 
(or the following conservative ammo acid changes from humans to rats and mice T15S P122S A159T 
and ТЭ56А. The nucleotide changes and deletions (Δ) η the DFN3 patients are indicated affected 
nucleotides are marked with a bar The asterisk ndtcates a stop oodon 
Table 1. Orticai features and POU3F4 mutations of patients with X linked deafness {21) The deafness 
type here β based on audiotogtc examination The POU3F4 mutations are named stop according to 
the last wild-type amno acid that remains η the predicted proten Blank spaces ndicate that no CT scan 
(second cxkxm) or stapedectomy (third cohjmn) was performed - designates that no mutations were 
found in POU3F4 
Patient Bony defect 
PenJyrnph 
gusher 
Deafness 
type 
POU3F4 
mutation Reference 
2412 
2540 
3055 
3105 
5274 
5736 
5623* 
2418 
2964 
3038 
3056 
5106 
5347 
5943 
2286 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
Yes 
Yes 
Yes 
Yes 
No 
Mixed 
Mixed 
Mrxed 
Mixed 
Sensorineural 
Mrxed 
Moed 
Sensorineural 
Sensorineural 
Sensorineural 
Sensorineural 
Sensorineural 
Sensorineural 
Sensorineural 
Conductive 
•Some DFN3-affected maternal reuses o< patent S823 abo have cataracts 31 
-
-L298stop 
D215 stop 
K202stop 
L317W 
K334E 
-
-
-
-
-
-
-
-
a young age 
1291 (5) 
(30) 
(30) 
(9) 
(9) 
00) 
(30) 
(30) 
(30) 
(30) 
0) (9) 
(9) (30) 
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premature stops of translation (Table 1 and 
Fig. 2). Patient Э055 carries a deletion of an 
A nucleotide at position 895 (Figs. 2 and 
3C), patient 3105 has a deletion of one G 
that is part of a GGCG tetranucleotide 
stretch at positions 64β to 651, and in pa­
tient 5274 a CAAA tetranucleotide is delet­
ed that is present in tandem at positions 603 
to 610 of the wild-type POU3F4 sequence. 
As shown in Fig. 3B by SSC analysis, the 
mutation found in panent 5274 cosegregates 
with the DFN3 phenotype in the whole 
family. Two patients had missense mutations 
in the POU3F4 gene. In patient 5736, we 
found a Τ to G transversion at position 950, 
whereas patient 5823 showed an A to G 
transition at nucleotide 1000. These muta­
tions result in the nonconservative L317W 
and K334E substitutions in the POU home-
odomain (21). 
The leucine residue at position 317 that 
is mutated in patient 5736 is located be­
tween helices 2 and 3 of the POU homeo-
domain, as deduced from nuclear magnetic 
resonance and crystallographic studies (22). 
It is conserved in six of seven members of 
the non-POU domain proteins that belong 
to the homeodomain superfamily (23) and 
in all POU domain proteins, except Oct-2 
and emb. Here, the leucine residue is sub­
stituted for a methionine and a tyrosine 
residue, respectively (24)- The wild-type ly­
sine residue at position 334 that is mutated 
m patient 5823 resides in helix 3 of the 
POU homeodomain. This residue is con­
served among all POU domain proteins and 
members of the homeodomain superfamily 
Ш, 24) and contacts the DNA backbone 
in the major groove in the proposed crystal 
structure of the engrailed homeodomain-
DNA complex, but not in the Oct-1 FOU 
domam—ocramer complex (22, 25). Thus, 
these data strongly suggest that all muta­
tions we observed in the POU3F4 gene are 
clinically relevant and give rise to DFN3. 
Because DFN3 is a rare disorder, the total 
number of DFN3 patients that can be in­
vestigated will remain limited. Neverthe-
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S S S 8 8 8 S В S S E S t 5 S « ¿ " 
«902 
I 
,C C\ 
/ T T \
 > w—I 
* * — ' е е «—>.· «Scrii 
ab i 
Ι 2 * « β · 7 · « ι β η β ΐ 8 κ τ 5 ΐ β ΐ 7 1« 
Flg. 3 . Mutation analysis of POU3F4. (A) PCR-SSC analysis of the homeodomain of POU3F4 in 14 
patients with X-linked deafness and a male control (46, XY) with the use of the primer set V (20) The 
observed SSC shifts are indicated by arrows. (B) PCR-SSC analysis of the DFN3 family of patient 5274 
(indicated by an arrow) with the use of primer set IV. Obligate earner females are marked as such in the 
pedigree (ardes with dots). DFN3 patients are Indicated with sodd squares; symbols with Ines designate 
deceased individuals. The asterisk Indicates the presence of a weak wild-type ( WT ) SSC band in lane 12. 
Of the four females at nsk of carrying the CAAA deletion, individual 10 carnes the wild-type POU3F4 
sequence, whereas individuals 7 , 1 3 . and 1S cany the mutation. (C) Nucleotide (nt) sequence of part of 
the POU homeodomain of patient 3055 and a control male. 
less, the identification of five mutations in 
seven DFN3 patients as compared to no 
single mutation in 100 control X chromo­
somes is statistically highly significant (26). 
Unexpectedly, three Xq21 microdele-
tions (G8314, II/7, and 1/1C) and one du­
plication (in patient 5086) that had been 
identified previously in patients with DFN3 
do not encompass the POU3F4 gene. In all 
four cases, the rearrangement is located 
proximal and 5' to POU3F4, with physical 
distances varying between 15 and 400 kb 
(Fig. IB). In none of these patients, nor in 
two others with either a perilymphatic 
gusher during stapes surgery or a temporal 
bone defect (patients 2412 and 2540), were 
point mutations detected in the POL/3F4 
gene. Thus, in these cases DFN3 may be 
caused by mutations that affect 5' noncod-
ing or regulatory sequences mapping farther 
upstream. Alternatively, these aberrations 
may affect the gross chromosomal structute 
and thus may affect expression of POU3F4. 
Another, less likely explanation might be 
the presence of other genes in Xq21.1 that 
can cause DFN3. 
In seven patients with X-linked senson-
neural deafness and in one with X-linked 
conductive deafness, mutations were not 
found in the TOU3F4 gene. This is not 
surprising because previous linkage studies 
had indicated that X-hnked deafness is het­
erogeneous. In at least one family with sen­
sorineural deafness, the defect has been ex­
cluded from Xq21 (9). In two other fami­
lies, linkage to the Xq21 and Xpll.3-p21.1 
regions has been found (27). Here, we dem­
onstrate that DFN3 is correlated with mu­
tations that affect the POU3F4 protein. At 
least five POU domain genes are expressed 
in different parts of the developing inner 
ear (28), and defects of POU domain genes 
may play a major role in the etiology of 
nonsyndromic hearing impairment. 
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7. Discussion and future prospects 
7.1. Xq21 deletions: genotype-phenotype discrepancies 
The molecular characterization of male-viable deletions and translocations in 
Xq21 has enabled the subdivision of this chromosomal band into 20 intervals 
and facilitated the refined physical assignment of more than 40 DNA markers 
in this region (chapter 2 and unpublished data). Most of the cvtogenetically 
visible deletions described are associated with a complex phenotype including 
choroideremia, mental retardation, and deafness. By correlating the clinical 
features in these patients with the size and location of the corresponding 
deletions, Cremers and coworkers [1990] were able to map and isolate the 
choroideremia gene. Employing the same strategy, we were able to pinpoint 
the disease loci for a specific form of deafness (DFN3) and mental retardation 
to small defined intervals of the Xq21 band [chapter 3]. The regional 
assignment of the DFN3 gene was further refined by the identification and 
characterization of even smaller, submicroscopic deletions in patients with 
non-syndromic X-linked deafness [chapters 4 and 5]. Cloning and detailed 
analysis of the critical region [chapters 5 and 6] enabled us to identify the 
human homologue of a murine candidate gene for deafness in the relevant 
interval and to show that this gene, P0U3F4 (POU domain containing gene, 
class III, factor 4), is mutated in patients with DFN3. These findings strongly 
suggest that P0U3F4 and DFN3 are identical [chapter 6]. 
There are other patients, however, who show obvious features of DFN3 (bony 
changes in the inner ear, gusher during stapes surgery or linkage to Xq21) but 
no apparent alterations of the POU3F4 gene. All of them have sizeable 
chromosomal rearrangements located 5' to P0U3F4. Recently, an additional 
pedigree with X-linked mixed deafness has been reported that presents an 
atypical DFN3 phenotype with severely dysplastic inner ear structures in the 
affected males [Piussan et al, 1995]. Molecular analysis of this family 
revealed a microdeletion encompassing locus DXS169 proximal to the 
P0U3F4 gene. However, the protein coding part of the P0U3F4 gene is not 
mutated in the DNA of this patient nor any of the other typical DFN3 patients 
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that have been shown to carry microdeletions or a duplication in the Xq21.1 
region [chapter 6; de Kok et al, unpublished data]. This latter finding is 
intriguing, because such structural aberrations have not been observed in 
healthy individuals, and thus, it is likely that they are causally related to the 
disease phenotype. 
There are several explanations for our findings. Another gene involved in 
DFN3 might be situated in the Xq21.1 region, but the existence of a second 
DFN3 locus in the vicinity of P0U3F4 is unlikely since no other open reading 
frames were identified within a 850-kb segment surrounding P0U3F4 when 
using the corresponding cosmids for exon trapping, subtractive cDNA 
selection or hybridization screening of a human fetal brain cDNA library. 
POU3F4 is characterized by a lack of introns and the presence of two long A-
rich stretches within the 3' untranslated region, features that are indicative of 
a retrotransposon or a duplication of a retrotransposed gene. Very likely, the 
putative ancestral retrotransposition event that inserted the transcript of a 
P0U3F4-\\ke gene in the Xq21.1 region did not include the promoter region of 
the original gene. Therefore, other regulatory sequences near the integration 
site may have taken over its transcriptional control. Duplication or deletion of 
these postulated control sequences could then result in an abnormal 
regulation of P0U3F4 and hence, hearing loss in the affected probands. 
Finally, transcriptional silencing of P0U3F4 may also be due to higher order 
chromatin disorganization resulting from chromosomal rearrangements in 
these patients. In Drosophifa this mechanism for the disruption of gene 
expression is well-documented and has been termed position effect 
variegation [for a recent review, see Karpen, 1994]. The Xq21.1 sequences 
juxtaposed to the P0U3F4 gene in the patients with deletions might be 
heterochromatic, and thus abolish expression of POU3F4. 
Recently, a similar effect has been postulated to account for the disease 
phenotype in two patients with aniridia. These probands, while lacking any 
alteration of the PAX6 open reading frame, have sizable chromosomal 
rearrangements at least 85 kb distally to the PAX6 gene that segregate with 
the disease phenotype [Fantes et al, 1995]. 
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The establishment and physical characterization of a cosmid contig covering a 
large portion of the chromosomal region around the P0U3F4 gene [chapter 5 
and unpublished data] is a prerequisite to test these hypotheses. 
Another striking and as yet unexplained observation is the absence of 
deafness in a previously described patient, NP [Tabor et al, 1983; chapter 3], 
who has a deletion spanning almost the entire Xq21 band including the 
POU3F4 gene [chapter 3]. A similar situation has been described for a patient 
(RvD) who lacks the choroideremia gene [CHM) but does not display the 
typical clinical features [Cremers et al, 1989]. In the latter case, this might be 
explained by the existence of a related gene, CHML (REP-2), that may be able 
to functionally replace the choroideremia gene [Cremers et al, 1994]. It is 
conceivable that specific allelic variants of REP-2 and/or other yet unknown 
proteins involved in the biochemical pathways underlying CHM pathogenesis 
may compensate for the lack of CHM gene product in patient RvD. 
Likewise, the existence of P0U3F4 homologues may account for the normal 
hearing in patient NP. In this respect, it would be interesting to examine 
whether this patient shows the anatomical changes in the inner ear that are 
characteristic for DFN3. 
The exceptional phenotype of patient NP might also be explained by the co-
occurrence of a second mutation. For the visual system of the fruit fly 
Drosophila me/anogaster such double-mutants that reverse the original mutant 
phenotype and restore normal function have been described [Smith et al, 
1991; W u e t a l , 1995]. 
7.2. Functional aspects of the DFN3 gene 
Complex signalling systems of transcription factors, morphogens and other 
regulatory proteins coordinate the temporal and spatial gene expression 
patterns in a developing organism. POU domain genes are functional 
components of these cascades and have been reported to be abundantly 
expressed in the developing inner ear [Ryan et al, 1991]. In the course of the 
studies described in this thesis the POU domain gene P0U3F4 was identified 
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as a candidate gene for DFN3 in the affected probands. Deletions as well as 
point mutations in the protein coding region of P0U3F4 confirmed the causal 
relationship between this gene and DFN3. All point mutations observed so far 
have occurred in the bipartite DNA binding domain which consists of an 
evolutionary highly conserved homeodomain and the POU-specific domain 
[for review see Rosenfeld, 1991; Verrijzer & van der Vliet, 1993]. Site-
directed mutagenesis of both domains argues for a role in protein-protein 
interactions as well as in site-specific, high-affinity DNA binding [Ingraham et 
al, 1990; Verrijzer et al, 1990; Treacy et al, 1991]. The observed mutations, 
therefore, are likely to interfere with binding of the POU3F4 protein to its 
target sequences in the genome and/or may hamper the interaction with other 
proteins. The rat homologue of the POU3F4 protein (Brain-4) preferably binds 
as a monomer to the consensus octamer motif (A/D4.5TTTGCAT [Mathis et al, 
1992], a sequence characteristic for the promoter region of both tissue-
specific and ubiquitously expressed genes [Kemler & Schaffner, 1990]. In the 
presence of adjacent response elements, however, cooperative binding of two 
POU3F4 molecules can be triggered [Mathis et al, 1992]. It has been 
demonstrated that homeodomain genes can operate as an activator and/or 
inhibitor of transcription [Monuki et al, 1990; He et al, 1991; Andrew & 
Scott, 1992]. Homo- and heterodimer formation might control this property by 
generating protein complexes with different characteristics or specificities 
[Mathis et al, 1992]. 
Northern blot analysis and in situ hybridization have demonstrated that 
POU3F4 is expressed in human fetal brain and fetal kidney [van der Maarel, 
unpublished results], in the developing neural tube and fetal brain of the rat, 
but not in mouse embryonic stem cells, nor in embryonal carcinoma cells PI 9 
and F9 [Mathis et al, 1992]. This expression pattern suggests that POU3F4 
exerts its function predominantly during early embryonic development, which 
is in line with its pivotal role in the ontogenesis of the inner ear. However, 
POU3F4 expression is not confined to embryonic tissues. In rats examined 
postnatally, transcripts were detected in specific parts of the central nervous 
system, i.e. hypothalamic nuclei that synthesize and secrete various 
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neuropeptide hormones [Mathis et al, 1992]. These findings raise the question 
as to why pathological changes in DFN3 patients are restricted to the inner 
ear. Sasaki and colleagues [1992] have put forward a 'cell type-dependent 
multi-switch' model that explains differential transcriptional activity of target 
genes in developmental stages and/or tissues by the combinatorial action of 
transcription factors (Fig. 3). 
tanket gene 
expression 
A& В activate AacdveteaiB 
Figure 3: Model of transcriptional regulation of a target gene through two ceM type- dependent 
transcription factors. 
The lower two graphs show the expression profiles of a target gene dependent on the regulatory 
properties of the transcription factors. These properties can change in different cell types or 
developmental stages (see text for details) which results in a differential target gene expression. When 
(or where) both transcription factors act as positive regulators, the target gene expression is 
continuously activated. On the other hand, when (or where) A is a transcriptional activator but В 
represses the expression of the target gene, transcriptional activity of the target gene is only achieved 
when the expression of A exceeds the expression of В (after Sasaki et al, 1992). 
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As has been shown in chicken [Sasaki et al, 1992] some homeodomain 
proteins with similar affinities for target genes are expressed in a temporally 
and/or regionally overlapping pattern. If these proteins act as transcriptional 
activators, the corresponding target gene will be expressed continuously. 
However, when one of them acts as a repressor, the homeodomain proteins 
compete for the target response elements and hence, expression of the target 
gene will depend on their relative abundance. Based on the distinct expression 
pattern of P0U3F4, and the presence of other differentially expressed 
homeodomain genes in the developing inner ear, it is possible that the 
POU3F4 protein exerts a dominant and critical role (as a transcriptional 
activator?) during the development of the inner ear structures affected in 
DFN3 patients. 
Alternatively, tissue-specific factors may exist that interact with P0U3F4 
during certain developmental stages, either by regulating the P0U3F4 gene 
itself, or by assisting POU3F4 in the regulation of other genes. It is 
conceivable that there are inner ear-specific proteins which function as 
'transcriptional adapters' by connecting POU3F4 to multimeric activator 
complexes. Such tissue-specific auxiliary factors that are part of composite 
activators may mediate the differential activation of certain genes and will 
minimize non-productive interactions between transcription factor and other 
potential target sequences [Andrew & Scott, 1992]. 
The first evidence for the existence of such auxiliary factors has come from 
the identification of the tissue- and promoter- specific coactivator ОСА-B (Oct 
coactivator from B-cells) that facilitates the В cell-specific activation of 
immunoglobulin promoters by either of the POU domain factors Oct-1 or Oct-
2 [Luo et al, 1992]. Recently, a transcriptional coactivator with a similar 
specificity has been described that may be related to, or even identical to, 
ОСА-B [Gstaiger et al, 1995; Strubin et al, 1995]. Yet another example has 
been reported for Drosophila melanogaster. The protein encoded by the gene 
extradenticle (exd) modulates the binding capacity of certain homeodomain 
proteins by cooperative binding to the target genes and therefore accounts for 
their specificity [Chan et al, 1994; van Dijk et al, 1994]. 
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On the other hand, POU3F4 may interact with tissue-specific negative factors 
(repressors) which would allow tissue-specific expression of the otherwise 
repressed target genes. Similar interactions have been reported for Sp1 and 
other transcriptional activators [Croston et al, 1991; Drapkin et al, 1993]. 
There is evidence that tissue-specific factors are also capable of modulating 
the autoregulatory properties of transcription factors. For example, the protein 
encoded by the ultrabithorax [ubx) gene in Drosophila melanogaster positively 
regulates its own expression in the visceral mesoderm, whereas it represses 
itself in the embryonic epidermis, nerve cord and imaginai discs. Similarly, 
other target genes of the Ubx protein (e.g. antennapedia [antp]) have been 
shown to be differentially regulated depending on the cellular and promoter 
context [Krasnow et al, 1989; Gould et al, 1990]. 
Against this background, it will be interesting to look for genes that regulate 
POU3F4 expression and to identify the target genes that are controlled by 
POU3F4 during early development. Identification of these genes will be a 
prerequisite for understanding the role of POU3F4 in inner ear development 
and will shed more light on the pathogenesis of DFN3. 
7.3. Nosological and clinical implications 
Until recently, the classification of X-linked deafness was based on 
audiometrie measurements and the age of onset of hearing loss in the 
affected individuals [Konigsmark & Gorlin, 1976; McKusick, 1990]. This 
classification has been challenged [Reardon et al, 1991; 1993], and possible 
diagnostic alternatives such as radiological examination by high resolution 
computer tomography [Michel et al, 1991; Phelps et al, 1991] and the 
assessment of oto-neurological features [Reardon et al, 1993] have been 
proposed. Indeed, audiometrie findings do not suffice as diagnostic criteria 
since in 'mixed' forms of deafness, like DFN3, the conductive element can be 
masked by profound sensorineural deafness. 
The identification of POU3F4 mutations as the underlying cause of disease in 
patients with a special type of X-linked deafness, DFN3, has rendered reliable 
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diagnosis possible in most of the affected families. Compared to (invasive) 
radiological examination, mutation detection in the coding region of POU3F4 
is relatively easy and fast because of its limited length and the absence of 
introns (for details, see chapter 6). In our hands, all patients with mutations in 
the P0U3F4 gene showed characteristic temporal bone defects upon CT 
scanning. Therefore, mutation screening should be performed routinely in all 
patients with suspected X-linked deafness before radiological examination is 
considered. Against this background, the designation "X-linked mixed 
deafness (DFN3)" should be changed to "X-linked deafness with a temporal 
bone defect (DFN3)". 
Ongoing molecular studies should soon reveal the genetic defect in patients 
with temporal bone defects that do not show mutations in the coding region 
of the POU3F4 gene. In these cases, DNA diagnosis has for the time being to 
rely on the segregation of closely linked polymorphic markers in families. 
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Summary 
The aim of this study was the fine mapping and cloning of a gene involved in 
X-linked mixed deafness (DFN3). X-linked поп-syndromic deafness accounts 
for approximately 5 % of hereditary hearing impairment in males [Reardon et 
al, 1993]. Linkage studies in families with isolated deafness have provided 
evidence for at least three X-chromosomal gene loci, one of which (DFN3) is 
located on the proximal long arm of the X-chromosome. This localization is 
supported by the phenotype of patients with male-viable deletions constituting 
part of the Xq21 band. In this thesis, the molecular characterization of such 
cytogenetically visible deletions is described that are associated with deafness 
and other clinical features. In the course of these studies, we have narrowed 
down the map position of more that 40 anonymous DNA markers from the 
Xq21 band (chapter 2) one of which, DXS995, turned out to be crucial for 
the definition of the DFN3 critical region. 
By correlating the molecular and clinical findings of the affected probands, the 
position of the underlying deafness gene was refined to a small interval in 
Xq21.1. Moreover, a gene locus for X-linked mental retardation was regionally 
mapped slightly distal to the DFN3 locus (chapter 3). In order to narrow down 
the critical region encompassing the DFN3 gene locus, we have performed a 
systematic search for additional chromosomal rearrangements in 13 unrelated 
patients with X-linked non-syndromic deafness. Employing DNA marker 
DXS26 from within Xq21.1, two submicroscopic deletions encompassing this 
locus were detected (chapter 4). As a prerequisite for accurate genetic and 
physical mapping of the Xq21.1 region we have focused on the identification 
of additional DNA markers and on the generation of a YAC contig in order to 
cover the region physically. Four human YAC libraries were screened with 
DNA markers from Xq21.1. In total, this search yielded 15 YAC clones two of 
which were shown to span several DFN3-related deletion breakpoints. Both 
YACs were subcloned into cosmids, and an 850-kb cosmid contig was 
constructed and analyzed in detail by restriction mapping and PFGE analysis. 
Cosmids from this contig were hybridized to DNA from 17 unrelated patients 
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with X-linked deafness. In this way, two novel microdeletions in the DFN3-
critical region were detected (chapter 5). 
After numerous attempts to identify expressed sequences in this region had 
failed, the human homologue of the mouse POU domain gene Brn-4 
{P0U3F4), which is expressed in the developing inner ear, was shown to 
cross-hybridize to the 850-kb cosmid contig. Cloning and characterization of 
this gene as a candidate gene for DFN3 enabled us to detect subtle P0U3F4 
mutations in several patients with DFN3 that result in truncation of the 
predicted protein or in non-conservative amino acid substitutions (chapter 6). 
These findings strongly suggest that POU3F4 mutations play a causal role in 
the aetiology of X-linked mixed deafness. However, some of the chromosomal 
rearrangements associated with DFN3 do not affect the protein encoding 
region of the human P0U3F4 gene. Subsequent studies that will include the 
analysis of the promoter region may clarify whether alterations in regulatory 
sequences or positional effects are the cause for hearing impairment in these 
patients. The data presented here have laid the foundation for the elucidation 
of the function of P0U3F4 and its role during inner ear development. 
Moreover, they provide a basis for an improved genetic classification of 
human X-linked deafness. 
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Samenvatting 
Het doel van deze studie was de fijnkartering en klonering van een gen 
betrokken bij X-gebonden gemengde doofheid (DFN3). Geschat wordt dat bij 
5% van de mannen met congenitale doofheid de oorzaak zich in een X-
chromosomaal gen bevindt. Koppelingsstudies in families met 
geslachtsgebonden doofheid toonden aan dat er zich tenminste 3 
verschillende genen voor doofheid op het X-chromosoom bevinden. Het gen 
voor DFN3 werd op deze manier gelokaliseerd in het Xq13-q22 gebied. 
Deze lokalisatie werd bevestigd met de identificatie van interstitiële deleties in 
Xq21 in patiënten met complexe ziektebeelden. In dit proefschrift beschrijven 
wij de moleculaire karakterisatie van deze cytogenetisch zichtbare deleties, 
welke geassocieerd zijn met doofheid en andere klinische verschijnselen. 
Gedurende deze studie hebben wij 40 anonieme markers nauwkeurig 
gepositioneerd in Xq21 (hoofdstuk 2). Een van deze markers, DXS995, bleek 
essentieel voor de kartering van het DFN3 gen. 
De correlatie van de moleculaire en klinische gegevens van deze patiënten 
maakte het mogelijk het DFN3 gen en een gen voor mentale retardatie in een 
klein interval van Xq21.1 te lokaliseren (hoofdstuk 3). Gebruik makend van 
DNA markers uit Xq21.1 werden twee microdeleties gevonden in patiënten 
met niet-syndromale DFN3 (hoofdstuk 4). Voor een nauwkeuriger analyse van 
het Xq21 gebied werden 'yeast artificial chromosome' (YAC) banken 
gehybridiseerd met DNA markers uit Xq21.1. Er werden 15 YAC clones 
geïsoleerd waarvan twee een substantieel deel van het kritische gebied voor 
DFN3 bevatten. Beide YACs werden gebruikt voor de constructie van een 
850-kb cosmid contig. Individuele cosmiden werden getest op het DNA van 
17 niet-verwante patiënten met X-gebonden doofheid. Deze studie maakte het 
mogelijk twee additionele deleties geassocieerd met DFN3 te identificeren 
(hoofdstuk 5). 
Na een aantal mislukte pogingen geexpresseerde sequenties uit het kritische 
gebied voor DFN3 te isoleren, werd de humane homoloog van het muizen 
POU domein gen Brain4 (POU3F4), welke tot expressie komt in het 
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embryonale binnenoor, gelokaliseerd in de 850-kb cosmid contig. Klonering en 
karakterisering van dit kandidaat gen maakte het ons mogelijk in diverse DFN3 
patiënten kleine P0U3F4 mutaties te vinden die resulteren in onvolledige 
POU3F4 translatie of niet-geconserveerde aminozuur substituties (hoofdstuk 
6). Deze bevindingen wijzen er sterk op dat POU3F4 mutaties een causale rol 
spelen in het ontstaan van X-gebonden gemengde doofheid. Enkele van de 
chromosomale veranderingen geassocieerd met DFN3 omvatten niet het eiwit 
coderende deel van het humane P0U3F4 gen. Vervolgstudies waarin o.a. de 
P0U3F4 promoter nauwkeurig geanalyseerd zal worden zullen mogelijk een 
antwoord kunnen geven op de vraag of positie-effecten de oorzaak zijn voor 
doofheid in deze patiënten. De resultaten beschreven in dit proefschrift 
vormen de basis voor studies die de exacte rol van het POU3F4 eiwit in de 
ontwikkeling van het binnenoor moeten ophelderen, en zullen aanleiding geven 
tot een verbeterde classificatie van X-gebonden doofheid. 
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List of abbreviations 
aa 
ВАС 
bp 
cDNA 
CGS 
CHM 
cM 
CPEO 
CSF 
CT 
DFN3 
DNA 
EBV 
EST 
FIGE 
GMS 
HAEC 
IAC 
kb 
Mb 
mt 
ORF 
PAR 
PCR 
PFGE 
RDA 
RFLP 
WS 
XCI 
XIC 
XLA 
YAC 
amino acid 
bacterial artificial chromosome 
base pair 
complementary DNA 
contiguous gene syndrome 
choroideremia 
centiMorgan 
chronic progressive external ophthalmoplegia 
cerebrospinal fluid 
computerized tomography 
X-linked, progressive mixed deafness 
deoxyribonucleic acid 
Epstein Barr virus 
expressed sequence tag 
field inversion gel electrophoresis 
genomic mismatch scanning 
human artificial episomal chromosome 
internal auditory canal 
kilobase 
megabase 
mitochondrial 
open reading frame 
pseudoautosomal region 
polymerase chain reaction 
pulsed field gradient gel electrophoresis 
representational difference analysis 
restriction fragment length polymorphism 
Waardenburg syndrome 
X-chromosome inactivation 
X-inactivation centre 
X-linked agammaglobulinemia 
yeast artificial chromosome 
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